Document:

Master Lease Agreement, dated November 1, 2005

 Exhibit 10.27 
 MASTER LEASE AGREEMENT 
 This Master Lease Agreement (this “Agreement”),
dated as of November 1, 2005 (the “Effective Date”), is between Aegis Communications Group, Inc, having its principal place of business at 8001 Bent Branch Drive, Irving, Texas 75063, together with its majority-owned
subsidiaries (“Aegis”), and NationsHealth, Inc., having its principal place of business at 13650 N.W. 8th Street, Sunrise, Florida 33325 (“NationsHealth”). 
 WHEREAS, Aegis has the capability to provide health
information management services, and NationsHealth has a need for such health information management services; 
 WHEREAS, NationsHealth is a
party to a Strategic Agreement among Connecticut General Life Insurance Company (“CIGNA”), NationsHealth and United States Pharmaceutical Group, LLC (“USPG”), dated as of May 4, 2005 (the “Strategic
Agreement”), pursuant to which NationsHealth provides certain marketing, enrollee communication, enrollee billing, enrollee premium collection, enrollment, and enrollee eligibility services to CIGNA in connection with the CMS-approved and
CIGNA-sponsored Prescription Drug Plan under the Medicare Part D program (the “CIGNA Medicare Part D Prescription Drug Plan”), which services will be referred to hereinafter as the “NationsHealth Medicare Part D
Services”; and 
 WHEREAS, Aegis and NationsHealth desire to enter into this Agreement setting forth the terms and conditions
pursuant to which NationsHealth will lease or otherwise obtain from Aegis, and Aegis will provide to NationsHealth, certain personnel, Capacity (as defined in Section 2(j) below) and other assets relating to health information management
services in connection with NationsHealth providing the NationsHealth Medicare Part D Services. 
 NOW, THEREFORE, NationsHealth and Aegis
hereby agree as follows: 
  

	 	1.	Scope of Agreement. This Agreement sets forth the terms and conditions that will apply to the combination of certain of Aegis’s employees, assets and premises that
together constitute Aegis’s operational capabilities to assist NationsHealth with NationsHealth’s Medicare Part D Services, which operational capabilities will be leased or otherwise provided by Aegis to NationsHealth.

  

	 	2.	Definitions. Except as otherwise specified, the following terms will have the respective meanings set forth below whenever used in this Agreement and will include the
singular as well as the plural: 

  

	 	(a)	“Advance” has the meaning set forth in Section (8). 

  

	 	(b)	“Aegis” has the meaning set forth in the preamble. 

  

	 	(c)	“Aegis Indemnified Parties” has the meaning set forth in Section 13(a). 

  

	 	(d)	“Aegis Non-Compete Covenants” has the meaning set forth in Section 11. 

  

	 	(e)	“Aegis Non-Renewal Notice” has the meaning set forth in Section 3 below. 

  

 - 1 - 

	 	(f)	“Agreement” has the meaning set forth in the preamble. 

  

	 	(g)	“Assets” has the meaning set forth in Section 4. 

  

	 	(h)	“Book Value” means the values assigned to the assets identified on Schedules 2, 3 and 4 attached hereto as of the Effective Date, subject to decrease as a result of
depreciation expensed in accordance with generally accepted accounting principles to reflect the appropriate value of a given asset as of the date of the applicable determination. 

  

	 	(i)	“Call” means a single telephonic contact to, from or on behalf of an enrollee or potential enrollee of the CIGNA Medicare Part D Prescription Drug Plan with respect
to that prescription drug plan, measured from the time it originates from or enters Aegis’s equipment to closure. 

  

	 	(j)	“Capacity” means the total number of physical, operational call center workstations for use by CSRs to perform the Services at an Aegis call center facility,
supported by all hardware, software, licenses and other rights necessary for the continued operation of such workstations. 

  

	 	(k)	“Capacity Fixed Assets” has the meaning set forth in Section 4(b). 

  

	 	(l)	“Capacity Forecast” has the meaning set forth in Exhibit A, Section (a)(2). 

  

	 	(m)	“Capacity Intangible Assets” has the meaning set forth in Section 4(b). 

  

	 	(n)	“CIGNA” has the meaning set forth in the preamble. 

  

	 	(o)	“CIGNA Data” means, collectively, all data and information (a) relating to providers, enrollees, and Customers of CIGNA, or (b) CIGNA’s Confidential
Information, or (c) CIGNA’s Intellectual Property. 

  

	 	(p)	“CIGNA Intellectual Property” or “CIGNA’s Intellectual Property” means all of CIGNA’s and its affiliates’ copyrights, patents,
service marks, trademarks, designs, logos, brand names, Internet “URL” addresses, World Wide Web sites and all right, title and interest in and to any trade names, fictitious business names and all other intellectual property rights
including all right, title and interest, including any license rights it has, in and to the names “CIGNA,” “CIGNA HealthCare,” “CIGNA Companies,” “Connecticut General Life Insurance Company,” and any
derivation thereof and including CIGNA New Intellectual Property. 

  

	 	(q)	“CIGNA Medicare Part D Prescription Drug Plan” has the meaning set forth in the preamble. 

  

	 	(r)	 “CIGNA New Intellectual Property” means all developed materials and other intellectual property that (a) are conceived, created or developed
in connection 

  

 - 2 - 

 
with or in the course of Aegis’s provision of Services, and are modifications, enhancements, adaptations or derivative works or derived from or based on
the CIGNA Data or CIGNA Confidential Information or any CIGNA Intellectual Property in all cases, regardless of who makes such modifications, enhancements, adaptations and derivative works of or derived from or based on the CIGNA Data or any CIGNA
Intellectual Property, or (b) are conceived, created or developed to address, execute or embody a CIGNA-specific product, service, business process, including any modifications, enhancements, adaptations and/or derivative works of or based on
any of the foregoing, in all cases, regardless of who conceives, creates, develops or makes any of the foregoing. 
  

	 	(s)	“Confidential Information” has the meaning set forth in Section 10. 

  

	 	(t)	“Connectivity Expenses” means all fixed and variable telecommunications charges and associated taxes and tariffs directly related to the performance of Services,
including, but not limited to, charges from telecommunications carriers for leased and local voice telephone lines, DIDs, data connectivity and Internet access. 

  

	 	(u)	“Contractors” has the meaning set forth in Section 11(e). 

  

	 	(v)	“Customer” means a customer of CIGNA, in its capacity as a prescription drug plan sponsor, calling or receiving outbound calls via telephone for information.

  

	 	(w)	“CMS” has the meaning set forth in Section 5(e). 

  

	 	(x)	“CSR” means an Aegis hourly production employee who performs Services for Customers. 

  

	 	(y)	“Deficiency” has the meaning set forth in Section 14(c). 

  

	 	(z)	“DID” means Direct-Inward-Dial, a service that enables callers to dial directly into an extension on a PBX (private branch exchange) and bypass the PBX’s
built-in auto attendant. 

  

	 	(aa)	“Effective Date” has the meaning set forth in the preamble. 

  

	 	(bb)	“Expected Number of Calls” means the expected number of Routed Calls for which NationsHealth will be using the Services during any period. 

 

	 	(cc)	“Expiration Date” has the meaning set forth in Section 3. 

  

	 	(dd)	 “Facility Expenses” means non-payroll expenses related to the lease and operation of an Aegis facility performing the Services incurred in the
ordinary course of business. Facility Expenses include, but are not limited to, rent, wear and tear facility maintenance that are the responsibility of the tenant, repairs required in the ordinary course of business that are the responsibility of
the tenant, customary 

  

 - 3 - 

 
facility insurance expenses, utilities, janitorial services, security services, property tax, training materials, supplies and other non-payroll expenses
incurred in the ordinary course of owning and operating a facility. 
  

	 	(ee)	“Handle Time” means the total time spent on a Call including consultation, CSR hold time, after-call work as may be required, and wrap-up of a Call, but excluding
any queue time. 

  

	 	(ff)	“HIPAA” has the meaning set forth in Section 5(e). 

  

	 	(gg)	“Leased Capacity” has the meaning set forth in Section 4(b). 

  

	 	(hh)	“Lease Payments” has the meaning set forth in Section 9. 

  

	 	(ii)	“Licensed Agent” means a CSR or Staff member that has obtained all licenses necessary for that CSR or Staff member to perform the Services.

  

	 	(jj)	“Licensing Expenses” means expenses associated with (i) a CSR becoming and remaining a Licensed Agent for the purposes of performing Services; and
(ii) expenses associated with Aegis acquiring and retaining such rights and licenses as may be required for Aegis to employ Licensed Agents 

  

	 	(kk)	“Managers” has the meaning set forth in Section 6. 

  

	 	(ll)	“Management Fees” has the meaning set forth in Section 9(c). 

  

	 	(mm)	“Month” means a calendar month. 

  

	 	(nn)	“NationsHealth” has the meaning set forth in the preamble. 

  

	 	(oo)	“NationsHealth Medicare Part D Services” has the meaning set forth in the preamble. 

  

	 	(pp)	“NationsHealth Indemnified Parties” has the meaning set forth in Section 13(b). 

  

	 	(qq)	“NationsHealth Termination for Cause” has the meaning set forth in Section 14(c). 

  

	 	(rr)	“NationsHealth Termination for Convenience” has the meaning set forth in Section 14(a). 

  

	 	(ss)	“New York Facility” means the Aegis call center located in New York, New York, as more fully described on Schedule 4, which has a maximum Capacity of 200
workstations and which is included in the Assets. 

  

	 	(tt)	“New York Expenses” has the meaning set forth in Section 9(d). 

  

	 	(uu)	“New York Purchase Option” has the meaning set forth in Section 15(a). 

  

 - 4 - 

	 	(vv)	“New York Purchase Price” has the meaning set forth in Section 15(a). 

  

	 	(ww)	“Operations Expenses” means non-payroll expenses incurred by Staff directly related to the effective discharge of the job responsibilities in support of the
Services. Examples of Operations Expenses include, but are not limited to, reasonable travel and lodging expenses and sales taxes relating to the Services. 

  

	 	(xx)	“Outbound Calls” means all Calls originating from either the New York Facility or the Port St. Lucie Facility, including, but not limited to, calls to Customers,
prospective customers or other calls related to the Services. 

  

	 	(yy)	“Payroll Expenses” means wage, salary, benefit, payroll tax, worker’s compensation and other direct expenses incurred by Aegis in employing personnel to
provide the Services. 

  

	 	(zz)	“Personnel” has the meaning set forth in Section 4(a). 

  

	 	(aaa)	“Port St. Lucie Expenses” has the meaning set forth in Section 9(e). 

  

	 	(bbb)	“Port St. Lucie Facility” means the Aegis call center located in Port St. Lucie, Florida, as more fully described on Schedule 4, which has a maximum Capacity of 325
workstations and which is included in the Assets. The parties acknowledge that Aegis currently uses not more than forty (40) workstations for purposes other than the Services, however, such workstations will be available for use by
NationsHealth in connection with the Services, and not used by any other party, within ninety (90) days of the Effective Date. 

  

	 	(ccc)	“Port St. Lucie Purchase Option” has the meaning set forth in Section 15(b). 

  

	 	(ddd)	“Port St. Lucie Purchase Price” has the meaning set forth in Section 15(b). 

  

	 	(eee)	“Prime Date” means the date that is six Months prior to the Expiration Date. 

  

	 	(fff)	“Prime Notice” has the meaning set forth in Section 15. 

  

	 	(ggg)	“Rolling Forecast” has the meaning set forth in Exhibit A, Section (I)(a)(2). 

  

	 	(hhh)	“Routed Calls” means the number of Customer Calls NationsHealth routes to Aegis during any period. 

  

	 	(iii)	“Services” means the services described in subsection (I)(a) of Exhibit A attached hereto provided by the Staff and CSRs using the Capacity, the Capacity Fixed
Assets and the Capacity Intangible Assets according to the procedures, protocols and methods directed by NationsHealth in support of the NationsHealth Medicare Part D Services. 

  

	 	(jjj)	“Service Standards” has the meaning set forth in Section 5(h). 

  

 - 5 - 

	 	(kkk)	“Staff” means an Aegis employee having his or her primary workplace in an Aegis facility performing Services and assigned in a supervisory, support, or management
role in furtherance of the Services. Staff employees include, but are not limited to, supervisors, team leads, recruiters, trainers, program and account managers, technical support, human resources, and quality and validation personnel.

  

	 	(lll)	“Strategic Agreement” has the meaning set forth in the preamble. 

  

	 	(mmm)	“Training” means the period or periods in which a CSR is engaged in formal or informal activities prior to providing Services, or period of periods in which a CSR
is temporarily assigned to activities other than providing Services. Training includes, but is not limited to, orientation training, licensing training and study, refresher training, HIPAA training, or other training activities necessary to enable
CSR to become a Licensed Agent and effectively provide Services. 

  

	 	(nnn)	“USPG” has the meaning set forth in the preamble. 

  

	 	3.	Term. Subject to Section 14 (Termination) below, the term of this Agreement will commence on the Effective Date and will continue for thirty-six (36) Months, after
which it will expire (the “Expiration Date”). This Agreement will automatically renew upon the same terms and conditions contained herein unless Aegis provides notice to NationsHealth that this Agreement will not renew within 10
days following the Prime Date; (such notice, an “Aegis Non-Renewal Notice”). 

  

	 	4.	Assets to be Leased or Provided. Aegis will lease or otherwise provide to NationsHealth under this Agreement the following items or assets (collectively the
“Assets”): 

  

	 	(a)	All Staff and CSRs of Aegis that are engaged exclusively in providing the Services (the “Personnel”). The Personnel will include employees that are employed either
as of the Effective Date or thereafter. The Personnel that are employed as of the Effective Date are identified on Schedule 1 together with their corresponding salary information. The parties acknowledge that Schedule 1 does not need to be completed
as of the Effective Date, but will be completed within fifteen (15) days of the Effective Date and as required by Section 5(e). 

  

	 	(b)	 All Capacity of the New York Facility and the Port St. Lucie Facility used by Aegis in providing the Services (the “Leased Capacity”). Subject to
Section 29 (Ownership), the Leased Capacity is supported by (i) all of the fixed assets owned or leased by Aegis that are used exclusively in connection with the Services and located at the New York Facility and the Port St. Lucie Facility
(including the lease agreements relating to the New York Facility and the Port St. Lucie Facility), including G3 telephone system and the computer systems; and (ii) the Avaya switch owned by Aegis in support of the Services, which is in use at
NationsHealth’s Plantation, Florida, facility (collectively, the “Capacity Fixed Assets”). The Capacity Fixed Assets are identified on Schedule 2, with 

  

 - 6 - 

 
corresponding Book Values. The parties acknowledge that Schedule 2 does not need to be completed as of the Effective Date, but will be completed within
fifteen (15) days of the Effective Date and as required by Section 5(e). Subject to Section 29 (Ownership), the Leased Capacity is also supported by all of Aegis’s intangible assets owned, leased or licensed that are used in
connection with the Services, including software relating to the telephone and computer systems (the “Capacity Intangible Assets”). The Capacity Intangible Assets are identified on Schedule 3, with corresponding Book Values. The
parties acknowledge that Schedule 3 does not need to be completed as of the Effective Date, but will be completed within fifteen (15) days of the Effective Date and as required by Section 5(e) 
  

	 	(c)	Workspace for three (3) NationsHealth staff members at the New York Facility and the Port St. Lucie Facility, and reasonable accommodation for workspace requirements associated
with periodic visits to those facilities from NationsHealth staff members. 

  

	 	5.	Representations, Warranties and Covenants of Aegis. Aegis represents, warrants and covenants the following: 

  

	 	(a)	Aegis represents and warrants that the Assets have, as of the Effective Date, a total Capacity of 468 workstations. Aegis further covenants that the Assets will have a total
Capacity of 525 workstations within 90 days of the Effective Date and thereafter throughout the term of this Agreement, and that Aegis will bear the costs associated with raising the total Capacity of the Assets (whether by building and outfitting
new workstations or making available workstations currently committed on other non-NationsHealth projects) from 468 workstations to 525 workstations. 

  

	 	(b)	Aegis represents and warrants that the Capacity is, as of the Effective Date, in good, operational condition with all hardware, software and infrastructure necessary for Aegis to
provide the Services. 

  

	 	(c)	 Aegis covenants that it will, through the term of this Agreement, maintain the Capacity in good, operational condition with all hardware, software and
infrastructure necessary for Aegis to provide the Services. Aegis will be responsible for all costs relating to repairs and maintenance of the Capacity, and will make all necessary repairs to comply with this covenant promptly upon discovery. For
avoidance of doubt, Aegis’s obligations under this Section 5(c) do not include Facility Expenses, which will be the sole responsibility of NationsHealth under Section 9(d). For further avoidance of doubt, subject to Section 5(a),
NationsHealth will be solely responsible under Section 9(g) for the costs associated with any upgrades, changes, or improvements to the Capacity or the infrastructure relating to the Capacity subsequent to the Effective Date; however, in the
event that Aegis wishes to make any such upgrades, changes or improvements to the Capacity or the infrastructure relating to the Capacity, Aegis 

  

 - 7 - 

 
will be reimbursed by NationsHealth for such upgrades, changes or improvements only if Aegis and NationsHealth agree on the upgrades, changes or improvements
prior to their execution. 
  

	 	(d)	Aegis covenants that it will screen and perform background checks, including any criminal records, as part of hiring all of the Personnel, and that it will terminate or remove from
the Services any of the Personnel that are unable to become a Licensed Agent. Aegis covenants that it will obtain such license(s) as may be necessary for it to employ Licensed Agents to perform the Services. 

  

	 	(e)	Aegis covenants that it will comply with the same restrictions and conditions that apply to NationsHealth pursuant to its Strategic Agreement with CIGNA with respect to
“Protected Health Information” as that term is defined under the Federal Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), and that it will implement reasonable and appropriate safeguards to protect
“Electronic Protected Health Information” as that term is defined under HIPAA. Moreover, Aegis covenants that it will comply with all instructions and guidelines of the Centers for Medicare and Medicaid Services (“CMS”),
and all applicable legal requirements including, but not limited to, requirements related to the record-keeping, any employee screening and/or health insurance agent or other necessary licensing requirements and requirements associated with HIPAA.
Aegis covenants that it will comply with all applicable Federal laws, regulations and CMS instructions that relate to this Agreement and its performance hereunder. 

  

	 	(f)	Aegis represents and warrants that, as of the Effective Date, it either owns, or has all necessary rights, licenses, leases and consents required to use the Capacity Fixed Assets,
the Capacity Intangible Assets, the New York Facility and the Port St. Lucie Facility, identified in Schedules 2, 3 and 4, respectively, in the manner currently used and proposed to be used under this Agreement, without interference, subject to
matters of record and the terms and conditions of applicable licenses, leases or other agreements affecting same; provided, that such matters of record and terms and conditions will not materially affect the Services contemplated under this
Agreement. Aegis covenants that it will maintain the right to use the Assets during the term of this Agreement, without interference, including making all payroll, licensing and lease payments. Subject to the terms and conditions of Aegis’s
lease agreements for the New York Facility and the Port St. Lucie Facility, respectively, Aegis covenants that NationsHealth will be permitted to exclusively brand the New York Facility and the Port St. Lucie Facility, including the use of the CIGNA
brand, as permitted by CIGNA. 

  

	 	(g)	Aegis covenants that it will immediately notify NationsHealth of any material changes to the Assets, and will provide NationsHealth with an updated version of Schedules 1, 2, 3 and
4 on a quarterly basis. The reports will be in a format agreed upon by the parties. 

  

 - 8 - 

	 	(h)	Aegis covenants that it will meet the standards relating to the Services set forth on Exhibit A (the “Service Standards”). 

  

	 	(i)	Aegis covenants that it will dutifully and rapidly execute actions and changes outlined and requested by NationsHealth consistent with this Agreement. 

  

	 	(j)	Aegis covenants that it will share with NationsHealth and implement Aegis’s best practices in its performance of the Services. 

  

	 	(k)	Aegis acknowledges that it may come into possession of NationsHealth’s data and electronic information and that such data and electronic information is the property of
NationsHealth. Aegis further acknowledges that it may come into possession of CIGNA Data, and that CIGNA Data is the property of CIGNA. Aegis covenants that its use and management of CIGNA Data will be as described in Exhibit B.

  

	 	(l)	Aegis represents and warrants that it has the requisite corporate power and authority to enter into and perform this Agreement in accordance with the terms hereof.

  

	 	(m)	Aegis represents and warrants that, as of the Effective Date, the execution and delivery of this Agreement has been duly authorized by all necessary corporate action and that no
further consent or authorization is required by Aegis, its board of directors or its stockholders. 

  

	 	(n)	Aegis represents and warrants that, as of the Effective Date, this Agreement has been duly executed and delivered by Aegis, and that upon execution and delivery this Agreement
constitutes the valid and binding obligations of Aegis enforceable against Aegis in accordance with its terms. 

  

	 	(o)	Aegis covenants that it will develop, with the assistance and approval of NationsHealth, a disaster recovery plan as further described in Exhibit C; provided, that
NationsHealth will bear the reasonable costs of any capital expenditures required to implement such disaster recovery plan. 

  

	 	(p)	Aegis covenants that it will maintain adequate physical security to ensure that Aegis complies with the covenants set forth in Sections (c), (d), (e) and (k) above, to be
agreed to by Aegis and NationsHealth. Aegis makes no other warranties concerning the Assets. 

  

	 	(q)	Subject to Sections 9(d) and 9(e), Aegis covenants that it will maintain through the term of this Agreement the level of insurance on the Assets, to the extent applicable, that is
in place on the Effective Date. 

  

	 	6.	 Retention of Authority for the Personnel. The Personnel will at all times remain employees of Aegis and not employees of NationsHealth. At such times as the
Personnel are providing Services hereunder, Aegis will designate managers of Aegis responsible 

  

 - 9 - 

 
for oversight of the Services, which managers will provide periodic reports, as requested, to NationsHealth (the “Managers”). Subject to
Section 13(a) (Indemnities) and Section 13(c) (Termination), and except for management decisions that Aegis, in its sole discretion, deems necessary to achieve the Service Standards, the Managers will direct and supervise the work of the
Personnel pursuant to the protocols, procedures, measurements and directives of NationsHealth. Without limiting the foregoing, and except as otherwise provided in this Section 6, during the term of this Agreement, NationsHealth will have the
authority and right to direct all lawful managerial decisions, including, but not limited to, the following relating to the Personnel and the Assets: (a) to determine the hiring, staffing and scheduling requirements for the Personnel;
(b) to determine the means and methods to be utilized by the Personnel in the provision of Services; (c) to change the directives regarding the means and methods to be utilized by the Personnel with respect to the Services at any time;
(d) to determine the compensation for the Personnel; (e) to determine the training for the Personnel; (f) to determine the business processes employed at the New York Facility and the Port St. Lucie Facility; (g) to determine the
employee performance guidelines which will apply to the Personnel; (h) to determine the content and method of Personnel communications during Calls; (i) the appearance and work environment of the New York Facility and the Port St. Lucie
Facility, including the right to make improvements, modifications and cosmetic changes thereto; and (j) determine the assignment of the Personnel to the Services, including, but not limited to, having the right to insist that any member of the
Personnel be removed from providing the Services at any time. Any exercise of authorities and rights by NationsHealth under this Section 6 will be taken in consultation with Aegis, provided however, such consultation will not limit
NationsHealth’s rights hereunder, and will be communicated jointly by NationsHealth and Aegis to the extent reasonably practical. 
  

	 	7.	Consents. The obligations of the parties relating to Section 15 hereunder are expressly conditioned upon Aegis obtaining all consents from third-parties to the extent
necessary for Aegis to (i) lease, assign, license, or otherwise transfer the Assets to NationsHealth; or (ii) to use the Assets in any manner not expressly permitted under any lease, license or agreement between Aegis and any relevant
third party. Aegis will use its commercially reasonable efforts to obtain such consents as required. 

  

	 	8.	Project Development Payment. On the Effective Date, NationsHealth will pay Aegis an advance of $750,000 to be applied the Lease Payments (as defined in Section 9 below)
relating to the Services (the “Advance”). Aegis will credit the Advance against amounts owed by NationsHealth to Aegis for Lease Payments as such Lease Payments accrue. If this Agreement is terminated for any reason, any amounts of
the Advance that have not been used to pay for Lease Payments that have accrued prior to the termination date will be returned to NationsHealth on the termination date. Within two days of the Effective Date, Aegis agrees to provide NationsHealth
written documentation of Aegis’s expenses incurred in connection with the Services, and for which Advance proceeds were spent. 

  

	 	9.	Payment for Services. NationsHealth will pay to Aegis for the Assets a lease payment equal to the sum of the following (collectively the “Lease Payments”):

  

	 	(a)	All CSR-related Payroll Expenses incurred by Aegis in providing the Services, including expenses incurred during Training. Such expenses include those expenses incurred prior to the
Effective Date and that specifically relate to the Services. 

  

 - 10 - 

	 	(b)	All Staff Payroll Expenses incurred by Aegis in providing the Services. Such expenses include those expenses incurred prior to the Effective Date and that specifically relate to the
Services. 

  

	 	(c)	[Redacted] 

  

	 	(d)	All of the Facility Expenses, Operations Expenses and Connectivity Expenses of the New York Facility included in the Assets, including those expenses incurred prior to the Effective
Date and that relate specifically to the Services (“New York Expenses”), provided however, if NationsHealth uses less than 50% of the Capacity of the New York Facility, NationsHealth will have the option upon sixty (60) days
written notice to reduce its obligation to pay the New York Expenses 50% (or some other percentage agreed to by Aegis and NationsHealth). If NationsHealth exercises this option, Aegis will be permitted to lease the Capacity not used by NationsHealth
to any person that does not violate Aegis Non-Compete Covenants contained in Section 11. 

  

	 	(e)	All of the Facility Expenses, Operations Expenses and Connectivity Expenses of the Port St. Lucie Facility that are included in the Assets, including those expenses incurred prior
to the Effective Date and that relate specifically to the Services (“Port St. Lucie Expenses”), provided however, if NationsHealth uses less than 50% of the Capacity of the Port St. Lucie Facility, NationsHealth will have the option
upon sixty (60) days written notice to reduce its obligation to pay the Port St. Lucie Expenses by 50% (or some other percentage agreed to by Aegis and NationsHealth). If NationsHealth exercises this option, Aegis will be permitted to lease the
Capacity not used by NationsHealth to any person that does not violate Aegis Non-Compete Covenants contained in Section 11. 

  

	 	(f)	The maintenance costs associated with the Avaya switch owned by Aegis and in use at NationsHealth’s Plantation, Florida facility. 

  

	 	(g)	 All improvements implemented at the New York Facility and the Port St. Lucie Facility, which are specifically requested to be made by NationsHealth in writing,
provided however, NationsHealth will not be responsible for the payment for capital expenditures necessary for Aegis to establish as set forth in this Agreement, the viability of the New York Facility and the Port St. Lucie Facility as operating and
functioning call centers with a total Capacity of 525 workstations capable of providing the Leased Capacity to NationsHealth. To the extent not a fixture, any improvements paid for by NationsHealth will become the property of NationsHealth, and, at
no additional cost to NationsHealth, will be returned to 

  

 - 11 - 

 
NationsHealth upon the termination of this Agreement or upon NationsHealth’s exercise of one or both of its Purchase Options, as the case may be, as set
forth in Section 15 (Purchase Options). NationsHealth will be responsible for the cost of repair of any damages to the facilities resulting from the removal of NationsHealth’s property upon the termination of this Agreement and, if
required under any facility lease, for the cost of restoring a given facility to its condition as it existed before any NationsHealth–approved improvements were made. 
  

	 	(h)	All Licensing Expenses. 

 Statements for the Lease Payments
will be invoiced, including back-up documentation relating to expenses, as follows: 
  

	 	i.	Invoices will be issued bi-weekly for Payroll Expenses and Management Fees as described in Section 9(a), 9(b) and 9(c) above. A final invoice for the bi-weekly activity will be
submitted to NationsHealth within fifteen (15) days following the end of each bi-weekly period. 

  

	 	ii.	Invoices will be issued monthly for expenses detailed in Sections 9(d), 9(e) and 9(f) above. A final invoice for the previous monthly period will be submitted to NationsHealth no
later than the 15th day following the month of the accrual of any expense incurred. Any expenses not reported within
ninety (90) days will be deemed waived by Aegis. 

  

	 	iii.	Terms for billing for all invoices will be net thirty (30) days. 

 Other than Payroll Expenses, Connectivity Expenses and any rent-related Facilities Expenses, Aegis will obtain NationsHealth’s prior written approval for any expenses for which Aegis seeks reimbursement from
NationsHealth that exceeds $25,000. Except for fees or expenses disputed in good faith by either party, which Aegis and NationsHealth agree to promptly discuss and attempt in good faith to resolve informally, any fees or expenses not paid within
thirty (30) days of when due will thereafter bear interest until paid at a rate equal to the lesser of (i) one percent (1%) per month, or (ii) the highest rate allowed by applicable law. If Aegis and NationsHealth cannot
informally resolve fees or expenses disputed in good faith within thirty (30) business days, Aegis and NationsHealth agree to appoint a mediator reasonably acceptable to both parties and attempt to resolve the dispute through mediation within
ten (10) additional business days. The decision of the mediator will not be binding on the parties. Aegis and NationsHealth agree to evenly divide the costs of any mediator selected by them. Unless otherwise agreed by the Aegis and
NationsHealth, upon resolution, fees and expenses that had been disputed in good faith will be immediately due and payable and will thereafter bear interest until paid according to this Section 9. 
  

 - 12 - 

	 	10.	Confidentiality. In connection with the activities contemplated by this Agreement, each party may have access to confidential or proprietary technical, financial or business
information of the other party (“Confidential Information”). Each party will protect the confidentiality of the other party’s Confidential Information. Aegis recognizes the extreme confidential nature of some or all of the
information it may receive, including confidentiality requirements established by HIPAA. Except as required by law or as necessary to perform under this Agreement, neither party will disclose the Confidential Information of the other party or use
such Confidential Information for the benefit of itself or any third party, and such Confidential Information will be used solely as required to perform this Agreement. Confidential Information will not include information that (i) was in the
public domain at or subsequent to the time it was communicated to the receiving party by the disclosing party through no fault of the recipient; (ii) was rightfully in receiving party’s possession free of any obligation of confidence at or
subsequent to the time it was communicated to the receiving party by the disclosing party; (iii) was developed by employees or agents of the receiving party independently of and without reference to any information communicated to the receiving
party by the disclosing party; or (iv) was communicated by the disclosing party to an unaffiliated third party free of any obligation of confidence. Other than as prevented by applicable law, the receiving party may disclose the Confidential
Information of the other party as necessary to establish its rights under this Agreement, in response to a valid court order, law, rule, regulation (including any securities exchange regulation) or other governmental action provided that
(a) the disclosing party is notified in writing prior to disclosure of the information and (b) the receiving party assists the disclosing party, at the disclosing party’s expense, in any attempt by the other to limit or prevent the
disclosure of the Confidential Information. 

  

	 	11.	Aegis Non-Compete Covenants. Aegis will adhere and comply with the following non-competition covenants (the “Aegis Non Compete Covenants”):

  

	 	(a)	 As of the Effective Date, during the term of this Agreement, and for a period of three (3) years following the termination of the Strategic Agreement or any
successor agreement thereto between NationsHealth and CIGNA, Aegis will not have any contracts, agreements, relationship, joint ventures or other business dealings with CIGNA, or any affiliate (as defined by federal securities laws) of CIGNA, unless
specifically agreed to in writing in advance by NationsHealth. Notwithstanding the foregoing, if either (i) the Strategic Agreement is terminated by CIGNA “For Cause” pursuant to Sections 6.05(a), (d), (e), (f) or (g) only
of the Strategic Agreement, as finally determined pursuant to Article IX of the Strategic Agreement (assuming that the provisions of Article IX have been invoked in an attempt to resolve a dispute with regard to the For Cause termination) or
(ii) NationsHealth or its affiliate USPG change their business operations such that they cease to offer the services that they are obligated to provide under the Strategic Agreement, then, if the conduct or action of Aegis (in and of itself and
not caused by NationsHealth) does not cause or contribute in any way to such termination by CIGNA, Aegis will be relieved of its obligations under the Aegis Non-Compete Covenant set forth in this Section 11(a) if, and solely to the extent, the
performance of those obligations would cause any interference with or 

  

 - 13 - 

 
restriction of CIGNA’s ability to exercise of any of its rights or NationsHealth’s ability to fulfill of any of its obligations under
Section 6.07(c) of the Strategic Agreement. Section 6.07(c) of the Strategic Agreement, and subsections (a), (d), (e), (f) and (g) of Section 6.05 of the Strategic Agreement to which Section 6.07(c) refers are
attached hereto as Exhibit G to this Agreement and incorporated herein. 
  

	 	(b)	As of the Effective Date, during the term of this Agreement, and for a period of eighteen (18) months following the termination of this Agreement, Aegis must not assist,
provide, advise or otherwise engage in any business relationship with any person or entity engaged in a healthcare related business, including, but not limited to, providing any infrastructure solution, agent training processes, licensure training,
sales methods, business solution architecture, right-to-purchase (co-managed) structuring, call flow or service treatment or expanded usage of agents for defined complimentary product sales, if the information or expertise developed by Aegis in
connection with the performance of the Services under this Agreement are used in connection with the provision of services or advice to such other person or entity. Notwithstanding the foregoing, and solely as it relates to CIGNA, if (i) either
the Strategic Agreement is terminated by CIGNA “For Cause” pursuant to Sections 6.05(a), (d), (e), (f) or (g) only of the Strategic Agreement, as finally determined pursuant to Article IX of the Strategic Agreement (assuming that
the provisions of Article IX have been invoked in an attempt to resolve a dispute with regard to the For Cause termination) or (ii) NationsHealth or its affiliate USPG change their business operations such that they cease to offer the services
that they are obligated to provide under the Strategic Agreement, then, if the conduct or action of Aegis (in and of itself and not caused by NationsHealth) does not cause or contribute in any way to such termination, Aegis shall be relieved of its
obligations under the Aegis Non-Compete Covenant set forth in this Section 11(b) if, and solely to the extent, the performance of such obligations would cause any interference with or restriction of CIGNA’s ability to exercise of any of
its rights or NationsHealth’s ability to fulfill of any of its obligations under Section 6.07(c) of the Strategic Agreement. Section 6.07(c) of the Strategic Agreement, and subsections (a), (d), (e), (f) and (g) of
Section 6.05 of the Strategic Agreement to which Section 6.07(c) refers are attached hereto as Exhibit G to this Agreement and incorporated herein. 

  

	 	(c)	As of the Effective Date, during the term of this Agreement, and for a period of eighteen (18) months following the termination of this Agreement, Aegis must not, directly or
indirectly, own or invest in (other than investments in publicly-traded companies that do not exceed three percent (3%) of any class of securities of any enterprise if such securities are listed on any national or regional securities exchange
or have been registered under Section 12(g) of the Securities Exchange Act of 1934, as amended) engage in, manage, operate, finance, control or participate in the ownership, management, operation, financing or control of, become a partner of,
or joint venture participant in, lend its name or assets to, or provide consultant or advisory services of any other services to any business that is competitive with the NationsHealth Medicare Part D Services in the United States.

  

 - 14 - 

	 	(d)	In support of its obligations under Sections 11(b) and 11(c) above, Aegis covenants that it will use its commercially reasonable efforts to cause its officers and affiliates (as
defined under the federal securities laws) to enter into side agreements with NationsHealth, in a form reasonably satisfactory to NationsHealth, containing non-competition covenants substantially similar to the Aegis Non-Compete Covenants.

  

	 	(e)	In support of its obligations under Sections 11(b) and 11(c) above, Aegis covenants that it will use its commercially reasonable efforts to cause its (i) Managers; and
(ii) unless otherwise approved by NationsHealth contractors directly engaged by Aegis on NationsHealth matters (“Contractors”) to enter into side agreements with NationsHealth, in a form reasonably satisfactory to
NationsHealth, containing non-competition covenants substantially similar to the Non-Compete Covenant. If Aegis is unable to obtain the side agreements described in this Section 11(e) from its Managers and Contractors, NationsHealth may in
writing request that Aegis remove such Managers or Contractors from providing Services, and Aegis will promptly comply with such request. 

  

	 	12.	NationsHealth Non-Compete Covenants. As of the Effective Date, during the term of this Agreement, and for a period of eighteen (18) months following the termination of
this Agreement, NationsHealth must not, directly or indirectly, unless approved in writing in advance by Aegis (i) provide stand-alone call center services to any person or entity that is a customer of Aegis during the term of this Agreement;
and (ii) implement or use any trade secrets or proprietary processes unique to Aegis and disclosed by Aegis to NationsHealth during the Term of this Agreement. 

  

	 	13.	Indemnities. 

  

	 	(a)	Aegis will be entitled to rely on and act in accordance with any instructions or directions provided to Aegis by NationsHealth. NationsHealth will defend, indemnify and hold
harmless Aegis and its subsidiaries, successors and assigns, and each of their officers, directors, agents, contractors, subcontractors and employees (collectively, the “Aegis Indemnified Parties”), from and against any and all
claims, liabilities, damages, fines, penalties, costs and expenses, including reasonable attorneys’ fees, arising out of or resulting from (i) Aegis acting in accordance with written instructions or directions from NationsHealth; or
(ii) any infringement of a United States patent, a trade secret, or any copyright, trademark, service mark, trade name or similar proprietary rights conferred by statute, by common law, or by contract alleged to have occurred as a result of
rights conveyed or materials provided by or on behalf of NationsHealth; provided, however, that such indemnification obligation will not be triggered in the event that claims are asserted or liability assessed against Aegis as a result of
(x) the gross negligence or willful misconduct of any of the Aegis Indemnified Parties; 

  

 - 15 - 

 (y) conduct by any of the Aegis Indemnified Parties that violates any federal, state or local statues,
regulations or ordinances; and (z) any conduct by and of the Aegis Indemnified Parties that fails to conform with the terms of this Agreement. 
  

	 	(b)	Aegis will defend, indemnify and hold harmless NationsHealth and each of its officers, subsidiaries, successors and assigns and each of their directors, agents, contractors,
subcontractors and employees (collectively, the “NationsHealth Indemnified Parties”), from and against any and all claims, liabilities, damages, fines, penalties, costs and expenses, including reasonable attorneys’ fees,
arising out of or resulting from the negligent acts or intentional misconduct of Aegis, arising out of or in any way connected with the Services, including, but not limited to, any claims of wrongful termination, discrimination, harassment,
workplace tort, breach of contract or for compensation or benefits or both, unless such liability results from specific instructions or directions by NationsHealth to Aegis that are in conformity with the terms of this Agreement.

  

	 	(c)	The party to be indemnified pursuant to this Section 13 will notify the indemnifying party within ten (10) days after receiving notice of a claim. Provided that the
indemnifying party defends any such claim, the indemnifying party will have control over the defense and settlement thereof, provided however, settlement of any claim will require the consent of the indemnified party unless the settlement includes
an unconditional general release of the indemnified party. The party to be indemnified will furnish, at the indemnifying party’s reasonable request and expense, information and assistance necessary for such defense. 

  

	 	14.	Termination. 

  

	 	(a)	NationsHealth will have the right to terminate this Agreement for convenience (a “NationsHealth Termination for Convenience”), without cause or reasons, upon
seventy (70) days written notice to Aegis at any time (i) only with respect to that portion of the Services provided in the New York Facility; or (ii) only with respect to that portion of the Services provided in the Port St. Lucie
Facility; or (iii) with respect to this Agreement in its entirety. For purposes of the preceding sentence, if NationsHealth exercises a NationsHealth Termination for Convenience only with respect to the New York Facility or the Port St. Lucie
Facility, then this Agreement will continue in full force and effect with respect to the Services that Aegis continues to provide. Under any NationsHealth Termination for Convenience, NationsHealth will be responsible for all costs associated with
the termination of any Personnel relating to the WARN Act and similar state employment laws that are required as a result of a NationsHealth Termination for Convenience, provided, that Aegis complies with all legal requirements applicable to
such termination, including notices required under the WARN Act, and such terminated Personnel, if any, are not subsequently employed by Aegis or its affiliates (as defined under the federal securities laws) for a period of at least 90 days after
such termination. 

  

 - 16 - 

	 	(b)	If NationsHealth materially breaches this Agreement (including a default in payments to Aegis) and fails to cure such default within thirty (30) days after receiving written
notice specifying the default from Aegis, then Aegis may terminate this Agreement as of the date set forth in such notice. For purposes of the foregoing sentence, amounts disputed in good faith only become due upon resolution of, and to the extent
that, the dispute is resolved in favor of payment. Notwithstanding any such termination by Aegis for nonpayment, NationsHealth agrees that it will be liable to, and promptly pay, Aegis for any and all unpaid fees and charges, including amounts
disputed in good faith when and to the extent the resolution of the dispute is in favor of payment. 

  

	 	(c)	If Aegis materially breaches this Agreement (other than for a failure to meet and maintain the Service Standards) and fails to cure such default within thirty (30) days after
receiving written notice specifying the default from NationsHealth, then NationsHealth may terminate this Agreement as of the date specified in such notice; provided, that no breach will result from Aegis following the instructions of
NationsHealth under this Agreement (a “NationsHealth Termination for Cause”). If Aegis fails to meet the Service Standards, and provided such failure does not result from Aegis following the instructions of NationsHealth under this
Agreement a (“Deficiency”) NationsHealth will provide Aegis with written notice setting forth the Deficiency relating to the Service Standards. If the Deficiency is not cured within five (5) days of such notice, NationsHealth
will be permitted to reduce the Management Fees by twenty-five percent (25%) for the period starting after the fifth (5th) day from such notice until the Deficiency is cured or the Agreement is terminated. If the Deficiency is not cured within thirty (30) days after the date of the initial notice, NationsHealth will be permitted to declare a
NationsHealth Termination for Cause. 

  

	 	(d)	The rights acquired or obligations incurred by Aegis and NationsHealth prior to any termination will not be affected. In the event of any termination under this Section 14,
Aegis will be entitled to receive Lease Payments accrued and payable to it as of the date of termination. Aegis and NationsHealth will not have any liability to each other for any costs, expenses or liabilities that are incurred or accrue after the
termination date. Aegis will comply with all legal requirements applicable to any termination, including notices required under the WARN Act. Upon expiration or any termination of this Agreement, NationsHealth and Aegis will, within thirty
(30) days, return to the other, or destroy all copies of Confidential Information and will certify, in writing, delivery or destruction of all such Confidential Information and copies thereof, unless such party is required by law to maintain
copies of any Confidential Information for a longer period. 

  

	 	15.	Purchase Options. On or before the Prime Date, NationsHealth will have the purchase options described in this Section 15. If Aegis has not received notice from
NationsHealth within 33 days before the Prime Date of NationsHealth’s intention to exercise one or both of its purchase options on a particular date before the Expiration Date, Aegis will send to NationsHealth, with copy to counsel, a certified
letter (the “Prime Notice”) informing 

  

 - 17 - 

 NationsHealth that it has within 30 days following transmittal of the Prime Notice to (i) notify
Aegis of its intention to exercise one or both of its purchase options; and (ii) the date of intended exercise, if any. Provided that NationsHealth has not already exercised one or both of its purchase options under this Section 15 and
that a Prime Notice has been sent to NationsHealth by Aegis, NationsHealth’s purchase options under this Section 15 will only vest with respect to the purchase options that NationsHealth indicates it will exercise in a written, timely and
adequate response to the Prime Notice. 
  

	 	(a)	Subject to Section 7 (Consents) and this Section 15, NationsHealth has the option, but not the obligation, at any time upon thirty (30) days written notice to Aegis,
to purchase or assume Aegis’s contractual rights and obligations in all, but not less than all, of the non-employee Assets specific to the Services at the New York Facility provided to NationsHealth, including the Capacity Fixed Assets and the
Capacity Intangible Assets associated with the New York Facility, excluding, however, any contingent liability associated with any related real property lease agreement or any contingent liability not relating to the Services (such
option, the “New York Purchase Option”) at the following price (the “New York Purchase Price”): 

  

	 	i.	If the New York Purchase Option is exercised prior to the Expiration Date, the New York Purchase Price will equal the sum of (i) the Book Value of the Assets being purchased,
plus (ii) the difference between $4,000,000 and one-half of the Management Fees received by Aegis as of the date the New York Purchase Option is exercised by NationsHealth. 

  

	 	ii.	If the New York Purchase Option is exercised upon or after the Expiration Date, or after a breach of this Agreement by Aegis that remains uncured for thirty (30) days, the New
York Purchase Price will equal the Book Value of the Assets being purchased. 

  

	 	(b)	Subject to Section 7 (Consents) and this Section 15, NationsHealth has the option, but not the obligation, at any time upon thirty (30) days written notice to Aegis,
to purchase or assume Aegis’s contractual rights and obligations in all, but not less than all, of the non-employee Assets specific to the Services at the Port St. Lucie Facility provided to NationsHealth, including the Capacity Fixed Assets
and the Capacity Intangible Assets associated with the Port St. Lucie Facility, excluding, however, any contingent liability associated with any related real property lease agreement or any contingent liability not relating to the
Services (such option, the “Port St. Lucie Purchase Option”) at the following price (the “Port St. Lucie Purchase Price”): 

  

	 	i.	If the Port St. Lucie Purchase Option is exercised prior to the Expiration Date, the Port St. Lucie Purchase Price will equal the sum of (i) the Book Value of the Assets being
purchased, plus (ii) the difference between $4,000,000 and one-half of the Management Fees received by Aegis as of the date the Port St. Lucie Purchase Option is exercised by NationsHealth. 

  

 - 18 - 

	 	ii.	If the Port St. Lucie Purchase Option is exercised upon or after the Expiration Date, or after a breach of this Agreement by Aegis that remains uncured for thirty (30) days,
the Port St. Lucie Purchase Price will equal the Book Value of the Assets being purchased. 

 Upon NationsHealth exercising
either or both of the Purchase Options, and subject to Section 7 (Consents), Aegis will execute and deliver to NationsHealth one or more of a Bill of Sale or Assignment and Assumption Agreement or both, the forms of which are attached hereto as
Exhibits D and E, respectively. Further, notwithstanding Section 30 (Non-Solicitation) below, NationsHealth must offer employment to all of the Personnel associated with the New York Facility or the Port St. Lucie Facility, as the case may be,
upon the exercise of a corresponding Purchase Option. The NationsHealth Purchase Options will not be affected by a Termination for Convenience or a Termination for Cause elected by Aegis so long as NationsHealth gives notice of the exercise of one
or both of the Purchase Options prior to the effective date of such termination. 
  

	 	16.	Reporting and Financial Covenants. Subject to Section 10 (Confidentiality) and consistent with applicable securities laws, including but not limited to Regulation FD,
during the term of this Agreement, Aegis will provide to NationsHealth, and NationsHealth will receive, a monthly balance sheet, a monthly statement of operations and a monthly statement of cash flows within thirty (30) days after the
conclusion of the month being reported. All annual financial statements furnished to NationsHealth under the terms of this Section 16 will be audited statements. All other documents furnished to NationsHealth under the terms of this
Section 16, such as quarterly and monthly financial statements, may be unaudited, provided however, if they exist as audited financial documents, then they will be provided to NationsHealth in their audited form. 

  

	 	17.	Notice of Bankruptcy. Each party will provide the other party at least ten (10) days written notice prior to filing a petition for bankruptcy protection or similar
proceeding, including, but not limited to, a receivership, assignment for the benefit of creditors or other reorganization proceeding (a “Bankruptcy Proceeding”). Each party will also provide immediate notice to the other party of
any Bankruptcy Proceeding being commenced against the notifying party on an involuntary basis. Aegis will take all reasonable actions required to permit NationsHealth to exercise one or both of its Purchase Options in the event that Aegis is
contemplating or becomes a party to a Bankruptcy Proceeding. 

  

	 	18.	Aegis Retention of Liabilities. Notwithstanding NationsHealth’s obligations to make the Lease Payments, and excluding NationsHealth’s rights upon exercise of one or
both of its Purchase Options, Aegis will retain all liabilities relating to the Assets, including, but not limited to, claims and causes of actions asserted by any of the Personnel. However, nothing in this Section 18 will extinguish the
parties’ respective indemnification obligations set forth in Section 13 (Indemnities). 

  

	 	19.	 Cooperation. NationsHealth will cooperate with Aegis by furnishing any information or performing any action reasonably requested by Aegis, which information
or action is 

  

 - 19 - 

 
necessary to the timely, and successful consummation of the transactions contemplated by this Agreement, including, without limitation, providing Aegis with
NationsHealth’s Subscription Account Number, if any, with the National Do-Not-Call registry and all other information reasonably requested by Aegis to ensure compliance with applicable law. 
  

	 	20.	Binding Nature and Assignment. This Agreement will be binding on the parties hereto and their respective successors and assigns, but neither party may assign or subcontract
this Agreement, in whole or in part, without the other party’s prior written consent following the provision of written notice as set forth in Section 22. 

  

	 	21.	Force Majeure. Except for NationsHealth’s payment obligation, each party will be excused from performance hereunder for any period and to the extent that it is prevented
from performing any services pursuant hereto, in whole or in part, as a result of an act of God, natural disaster, war, civil disturbance or state of emergency and that it could not have prevented by reasonable precautions. 

 

	 	22.	Notices. Notices provided for in this Agreement will be in writing and will be delivered by hand, by overnight mail or by certified mail, return receipt requested, to the
parties at the following addresses, or such other addresses either party may provide to the other party in writing, and will be deemed delivered and received three (3) days after being sent: 

 If to Aegis Communications Group: 
 Aegis Communications Group, Inc. 
 8001 Bent Branch Drive 
 Irving, Texas 75063 
 Fax No.: (972) 868-0218 
 Attn: Chief Executive Officer 
 If to NationsHealth: 
 NationsHealth, Inc. 
 13650 N.W. 8th Street 
 Sunrise, Florida 33325

 Attn: Chief Operating Officer 
 With a copy to: 
 McDermott, Will & Emery, LLP 
 201 S. Biscayne Blvd., 22nd Floor 
 Miami, Florida 33131 
 Attn: Ira J. Coleman, Esq. 
  

 - 20 - 

 AND 
 CIGNA HealthCare, S-201 
 900 Cottage Grove Road 
 Hartford, CT 06152-2201 
 Attn: Rhonda M. Karlin, Esq. 
  

	 	23.	Severability. If any provision of this Agreement is invalid or unenforceable, the Agreement will be construed as if such invalid or unenforceable provision was not included
and the remainder of the Agreement will be enforced as written in a manner as close to the original intent of the parties. 

  

	 	24.	Waiver. No provision of this Agreement will be deemed waived, amended or modified by either party unless such waiver, amendment or modification is in writing and signed by
the party against whom enforcement of the waiver, amendment or modification is sought. Any such amendment or modification will be binding with or without tender of consideration. A waiver by either of Aegis or NationsHealth of any of the covenants,
conditions or agreements to be performed by the other or any breach thereof will not be construed to be a waiver of any other or succeeding breach or of any other covenant, condition or agreement contained in this Agreement.

  

	 	25.	Relationship of Parties. Aegis is performing pursuant to this Agreement only as an independent contractor. Nothing set forth in this Agreement will be construed to create the
relationship of principal and agent, joint venture or partnership between NationsHealth and Aegis. 

  

	 	26.	Survival. Expiration or termination of this Agreement for any reason will not release either party from any liabilities or obligations set forth in this Agreement that
(a) Aegis and NationsHealth have expressly agreed will survive any such expiration or termination, or (b) remain to be performed or by their nature would be intended to be applicable following any such expiration or termination.

  

	 	27.	Entire Agreement. This Agreement, together with each schedule and exhibit attached hereto or thereto, constitute the entire agreement between Aegis and NationsHealth and
supersedes any and all prior or contemporaneous oral and written communications, understandings or agreements relating to the subject matter hereof. 

  

	 	28.	Governing Law. This Agreement will be governed by and construed in accordance with the laws, other than choice of law rules, of the State of Florida.

  

	 	29.	Ownership. Aegis’s ownership of, or contractual rights in, all systems, software, documentation, utilities, tools, methodologies, specifications, techniques and other
materials, know-how, and hardware owned by Aegis or in the possession of Aegis prior to the Effective Date of this Agreement and used and developed by Aegis in connection with providing the Services, together with the intellectual property rights
therein, will remain with Aegis, unless expressly sold or assigned by Aegis to NationsHealth as a result of NationsHealth’s exercise of one or both of the Purchase Options. 

  

 - 21 - 

	 	30.	Non-Solicitation. During the term of this Agreement and for one (1) year after its conclusion, neither party will directly or indirectly, solicit the hiring or retention
of, recruit, employ or otherwise engage as an employee, independent contractor or advisor, or attempt to solicit, recruit, employ or otherwise engage as an employee, independent contractor or advisor any person who is or was an employee or
independent contractor of the other party at any time during the preceding twelve (12) months, provided however if Aegis provides an Aegis Non-Renewal Notice, NationsHealth will be permitted to employ any CSR trained to provide the Services
without restriction after the termination date, regardless of whether NationsHealth exercises either of its Purchase Options. 

  

	 	31.	Injunction Relief. Aegis and NationsHealth agree that in the event of any actual or threatened breach of the provisions of this Agreement, the non-breaching party will be
entitled (in addition to any and all other rights and remedies at law or in equity for damages or otherwise, which rights and remedies are and will be cumulative) to specific performance, a temporary restraining order, or an injunction to prevent
such breach or contemplated breach, without the necessity of the posting of a bond. 

  

	 	32.	Right to Inspect and Audit. NationsHealth, CIGNA, and CMS will have the right, directly or through their designated auditors, at all reasonable times to inspect, audit, or
otherwise evaluate the work performed or being performed by Aegis, its supporting policies and procedures, including those related to data security, disaster recovery and back-up, as well as all data supplied, in the performance of this Agreement,
including the calculation of the Lease Payments. If any inspection or evaluation is made by NationsHealth, CIGNA or CMS on the premises of Aegis, Aegis will provide at no additional charge all reasonable facilities and assistance for the safety and
convenience of the personnel conducting the inspection or evaluation. The Secretary of Health and Human Services, the Comptroller General of the U.S. Government Accountability Office, or their designees will have the right during the term of this
Agreement and for a period of four (4) years after termination of this Agreement or the date of the audit completion, whichever is later, to audit, evaluate, or inspect any books, contracts, medical records, documents, papers, enrollee
documentation, and other records of Aegis, Aegis’s related entities, subcontractors, or transferees that pertain to any aspect of the Services provided under this Agreement, or as the Secretary may deem necessary to enforce the applicable
Medicare contract between CMS and CIGNA, and each party to this Agreement will be responsible for its own labor and out of pocket expenses relating to that audit. Aegis further represents, warrants, and covenants to NationsHealth and CIGNA that, in
connection with the performance of the Services hereunder, Aegis will not hold enrollees liable for fees that are the responsibility of CIGNA. 

  

	 	33.	Authorization. This Agreement is effective only when signed by the Chief Executive Officer of Aegis. 

  

	 	34.	CIGNA as Third Party Beneficiary. Notwithstanding any provision to the contrary in this Agreement, CIGNA is a third party beneficiary to this Agreement, and CIGNA will be
entitled to enforce all provisions that are intended for its benefit. 

  

 - 22 - 

 IN WITNESS WHEREOF, each party has caused its authorized representative to execute this Agreement as of
the Effective Date. 
  

			
	AEGIS COMMUNICATIONS GROUP, INC.
		
	By:	 	 /s/ Kannan Ramasamy

		
	Name:	 	 Kannan Ramasamy

	Title:	 	Chief Executive Officer
	
	NATIONSHEALTH, INC.
		
	By:	 	 /s/ Glenn Parker

		
	Name:	 	 Glenn Parker

		
	Title:	 	 CEO

 Schedule 1 
 Leased Employees 

 Schedule 2 
 Leased Fixed Assets 
 Port St. Lucie 
 Floor 1 
 144 CSR Workstations 
 15 Admin Workstations 
 Agent Workstation: Dell Optiplex G1 
 Agent Monitor: Dell D1028L 
 Agent Operating system: Windows NT 
 Agent Ram in MB: 128 
 Agent phones: Avaya 8410B 
 Admin Workstation: Dell GX100 
 Admin Monitor: Dell D1028L 
 Admin Ram in MB: 128 
 Admin phones: Avaya Callmaster IV 
 IE Version: 6.0 
 Floor 2 
 164 CSR Workstations 
 13 Admin Workstations 
 Agent Workstation: Dell Optiplex G1 
 Agent Monitor: Dell D1028L 
 Agent Operating system: Windows NT 
 Agent Ram in MB: 128 
 Agent phones: Avaya Callmaster IV 
 Admin Workstation: Dell GX100 
 Admin Monitor: Dell M781p 
 Admin Ram in MB: 128 
 Admin phones: Avaya Callmaster IV 
 IE Version: 6.0 
 1 Avaya G3r PBX 
 20 Servers 
 New York City 
 10th floor 
 128 CSR Workstations 
 3 Admin Pods 
 Agent Workstations: Dell GX100

 Agent Monitor: Dell M990/M991 
 Agent Operation System: NT 4 
 Agent Phones: Avaya Callmaster V 
  

 S2 - 1 

 Admin Workstations: Dell GX100 
 Admin Monitors: Dell M990 
 Admin Operation System: Windows 2000 
 Admin Phones: Avaya 64080+ 
 IE Version: IE6 
 11th floor 
 72 CSR Workstations 
 2 Admin Pods 
 Agent Workstations: Dell GX100 
 Agent Monitor: Dell M990M991 
 Agent Operation System: NT 4 
 Agent Phones: Avaya Callmaster V 
 Admin Workstations: Dell GX100 
 Admin Monitors: Dell M990 
 Admin Operation System: Windows 2000 
 Admin Phones: Avaya 64080+ 
 IE Version: IE6 
 10th Floor 
  

	1	AVAYA G3R 

	5	DELL 350 SERVERS 

	1	DELL 2300 SERVER 

	2	CISCO 3640 

	1	HP PROCURVE 2524 

	2	HP PROCURVE 4108 

	2	SUN MICROSYSTEMS ENTERPRISE SERVER 3500 WITH MONITOR 

	1	STARTECH 16 PORT KEYBOARD/MOUSE BOX 

 11th Floor 
  

	1	AVAYA G3R 

	1	DELL 350 SERVERS 

	0	DELL 2300 SERVER 

	1	CISCO 3640 

	0	HP PROCURVE 2524 

	2	HP PROCURVE 4108 

	0	SUN MICROSYSTEMS ENTERPRISE SERVER 3500 WITH MONITOR 

	1	STARTECH 16 PORT KEYBOARD/MOUSE BOX 

  

 S2 - 2 

 Schedule 3 
 Leased Intangible Assets 
 Port St. Lucie 
 Witness 5.20.3.54 
 Agent Workstations: NT workstation 
 Admin Workstations: Windows 2000 
 New York City 

 Schedule 4 
 Leased Premises 
 Port St. Lucie Facility 
 10011 South U.S. Highway 1 
 Port St. Lucie, FL 34952 
 Approx. 42,000 sq. ft. 
 13 Admin offices 
 1 Conference Room

 3 Training rooms 
 New York City Facility

 80 Broad Street 
 New York, NY 10004 
 Approx. 20,000 sq. ft. 
 10th Floor 
 2 executive Offices 
 25 Seat Training room 
 Break Room 
 11th floor 
 25 Seat Training room 
 Break Room 
 Conference Room 
 Computer Room 
 IT/UPS Room 

 EXHIBIT A 
 SERVICE STANDARDS 
 Aegis will establish and maintain throughout the term of this Agreement the following
systems and infrastructure and service standards in the performance of its obligations under this Agreement: 
 I. SYSTEMS
AND INFRASTRUCTURE. 
  

	 	(a)	General Description of Telephone Services:  

 (1) To
provide telephone inbound and outbound inquiry and enrollment support services (the “Services”) to Customers (to include a Customer’s representative) via Routed Calls and Outbound Calls. Initially the Services will be provided
Monday through Friday from 8:00 AM – 11:00 PM local time for those time zones where the CIGNA Medicare Part D Prescription Drug Plan is offered, including the continental United States, Hawaii, and Alaska, unless Aegis and NationsHealth agree
otherwise. Services may need to be provided on Saturdays, but will not be provided on Sunday. NationsHealth reserves the right to modify the foregoing hours of operation, provided however, prior to any material change to the hours of operation,
NationsHealth will provide Aegis with two (2) weeks prior written notice. Notwithstanding such notice requirement, Aegis will take all reasonable steps to implement any requested change to the hours of operations. 
 (2) Call Volumes. 
  

	 	•	 	Demand Forecasting. Promptly following the Effective Date, NationsHealth will provide Aegis a written, rolling forecast of the Expected Number of Calls NationsHealth will
send to Aegis in a subsequent three-Month period, with adjustments made every subsequent Month (a “Rolling Forecast”). The initial Rolling Forecast will be made as of the Agreement date. Aegis and NationsHealth agree to keep Rolling
Forecasts confidential. 

  

	 	•	 	Capacity Forecasting. Simultaneously upon receipt of the first Rolling Forecast, Aegis will provide NationsHealth with a written, rolling forecast of the maximum capacity for
each of its facilities performing Services for NationsHealth in a subsequent three-Month period, with adjustments made every subsequent Month (a “Capacity Forecast”). NationsHealth will use the Capacity Forecast to help plan volume
allocations. Aegis and NationsHealth agree to keep Capacity Forecasts confidential. 

  

	 	•	 	Routed Calls. NationsHealth will distribute Calls to Aegis using an agreed-upon technology platform. Aegis will accept all calls offered it by NationsHealth during the hours
of operation. 

	 	(b)	Systems Services; Support Requirements: 

 (1) with
the support and resources provided by or otherwise arranged through NationsHealth, to track and monitor inbound and outbound member calls and to collect and report statistics on response times and accuracy and call abandonment rates. 
 (2) to monitor and audit each area of service to determine compliance with quality, service levels, and accuracy standards agreed-upon by Aegis and
NationsHealth. 
 (3) NationsHealth will provide or cause to have provided data connectivity and access to all necessary applications in
order to provide the Services. 
 (3) Aegis will provide NationsHealth with the appropriate allocation of DID numbers in order to receive
Routed Calls provided to the Aegis facilities in New York, New York and Port St. Lucie, Florida. 
 (4) Equipment and Software. Aegis will
provide a sufficient number of computers with associated application software (and maintenance parts for those computers) as required to provide the Services. In the event that NationsHealth’s system requirements require Aegis to expand its
platform beyond a standard workstation, Aegis and NationsHealth agrees to develop a plan for such expansion including associated costs to NationsHealth, setting forth assets similar to those set forth on Schedules 2 and 3, as well as any and all
other assets necessary to facilitate such expansion. 
  

	 	(c)	Data Management and Reporting Processes: 

 (1) to
enable NationsHealth to fulfill its reporting obligations to CIGNA under the Strategic Agreement with respect to call center measures and statistics. 
 (2) to provide information to NationsHealth to enable NationsHealth to manage and monitor the services and systems described in this Exhibit A. Aegis will furnish NationsHealth the information necessary for
NationsHealth to create management reports consistent with the format, content and timing of management reports that NationsHealth is obligated to furnish under the Strategic Agreement or as otherwise agreed upon between NationsHealth and CIGNA.

  

	 	(d)	Compliance with Service Level Standards: 

 to meet
the service level standards (also referred to herein as “service level agreement,” or “SLA”)agreed upon or to be agreed upon by CIGNA and NationsHealth pursuant to the Strategic Agreement, which standards will set forth
timeliness, accuracy and quality standards in addition to, or in excess of, the standards that are set forth in CMS instructions and guidelines. 

	 	(e)	Compliance with a Disaster Recovery and Business Continuation Plan: 

 to ensure business continuity through adherence to the disaster recover and business continuation plan established or to be established by CIGNA and NationsHealth pursuant to the Strategic Agreement. 
 II. CUSTOMER COMMUNICATIONS 
  

	 	(a)	In accordance with applicable CMS requirements set forth at 42 C.F.R. § 423.50, the CMS Marketing Guidelines applicable to the Medicare Part D Prescription Drug Plan, and the
CMS Marketing Guidelines applicable to the Medicare Part D Prescription Drug Plan, Aegis will, annually and at the time of enrollment, provide Customers (which term, when used in this Exhibit A will include Customers’ representatives, as the
context warrants) information on the following features of the CIGNA Medicare Part D Prescription Drug Plan: 

  

	 	•	 	Enrollment procedures; 

  

	 	•	 	Customer Procedural Rights; 

  

	 	•	 	Potential for contract termination; 

  

	 	•	 	Prescription Drug Plan benefits for standard Part D benefits; 

  

	 	•	 	Types of pharmacies in the pharmacy Network; 

  

	 	•	 	Out-of-network pharmacy access; 

  

	 	•	 	Premiums; 

  

	 	•	 	Service Area; 

  

	 	•	 	Current CIGNA Medicare Part D Prescription Drug Plan formularies; 

  

	 	•	 	60-days notice to potential and current Customers of the removal or change in the placement of any drug on the formulary; 

  

	 	•	 	Information about quality and performance indicators; 

  

	 	•	 	Information about utilization management procedures; 

  

	 	•	 	Information about the frequency of Customer grievances and appeals; and 

  

	 	•	 	Information on CIGNA’s financial condition. 

  

	 	(b)	Aegis will maintain a toll-free customer service call center that is open during usual business hours and provides customer telephone service for potential and current Customers in
compliance with standard business practices. NationsHealth will pay the expenses of the toll free telephone numbers. Aegis agrees to operate the call center in accordance with the following: 

 (1) The call center will operate Monday through Friday from no less than 8:00 AM – 11:00 PM local time for those time zones where the CIGNA Medicare
Part D Prescription Drug Plan is offered, including the continental United States, Hawaii, and Alaska, unless Aegis and NationsHealth agree otherwise; 

 (2) Eighty percent of all incoming Customer calls will be answered within 30 seconds; 
 (3) The abandonment rate of all incoming Customer calls will not exceed 5 percent; 
 (4) The call blockage (i.e. busy signals) rate will be set forth in the SLA; 
 (5) The call center will provide thorough information about the CIGNA Medicare Part D Prescription Drug Plan’s benefit plans, including co-payments,
deductibles, and network pharmacies; 
 (6) The call center will incorporate procedures for handling Customer complaints; 
 (7) Unless NationsHealth otherwise provides or arranges for non-English speaking services, the call center will provide service to non-English speaking
and hearing impaired Customers to be agreed upon by Aegis and NationsHealth; 
 (8) The call center will provide the information described in
paragraph II(a) above. NationsHealth will provide the information within its, or its designee’s, possession to Aegis or provide the requisite tools to enable Aegis’s access to such information. 
 (9) The call center will refer appeals and coverage determination issues, provider inquiries, and potential fraud and abuse matters to CIGNA. 

 

	 	(c)	Additional Obligations of Aegis related to Customer Communications. 

 (1) Aegis will require its employees, agents, and representatives engaged in marketing the CIGNA Medicare Part D Prescription Drug Plan to receive training in CMS’s Medicare marketing and enrollment instructions
and guidelines before they are permitted to talk with prospective Customers. Each such employee, agent, and representative will sign a form acknowledging that he or she has received such training. CIGNA, acting directly or through NationsHealth,
will have a reasonable period of time within which to review, and comment on, any training materials. Aegis will comply with all the requirements and instructions provided by NationsHealth, which will be acting on behalf of CIGNA in providing such
requirements and instructions, with regard to the content of Aegis’s communications with Customers. Aegis will comply with all applicable laws and regulations in the performance of the Services, including instructions and guidelines of CMS and

 
Medicare Services. Aegis will train its CSRs using NationsHealth’s training curriculum, which will have been approved by CIGNA, and will include, but
not be limited to, HIPAA training. 
 (2) Aegis, through the support and resources provided by or otherwise arranged through NationsHealth,
will assist in reporting to CIGNA the number of calls answered in 30 seconds or less, average call handle time, minimum and maximum handle times, and related statistics. The form, content and frequency of such reports will be agreed to by Aegis and
NationsHealth. It is currently anticipated that NationsHealth will use an outside vendor to monitor and provide this information to CIGNA on Aegis’s behalf. 
 (3) Aegis, through the support and resources provided by or otherwise arranged through NationsHealth, will monitor and/or record for later review no less than three calls per month for each Aegis call center
representative. It is currently anticipated that NationsHealth will use an outside vendor to monitor and provide this information on Aegis’s behalf. Aegis and NationsHealth will agree upon standards against which the quality and accuracy of
such monitored or review/call will be assessed. Aegis, in connection with NationsHealth, will report the results of its call center monitoring and review on a quarterly basis, together with any corrective actions taken with respect to call center
personnel who fail to meet the acceptable quality levels agreed upon by Aegis and NationsHealth. 
 (4) Aegis, through the support and
resources provided by or otherwise arranged through NationsHealth, will report to CIGNA the average hold times for calls, call abandonment rates, and related statistics. It is currently anticipated that NationsHealth will use an outside vendor to
monitor and provide this information on Aegis’s behalf. The form, content and frequency of such reports will be agreed to by Aegis and NationsHealth. 
 (5) Aegis, through the support and resources provided by or otherwise arranged through NationsHealth, will provide call center statistics as specified in CMS’s Final Medicare Part D Reporting Requirements in
sufficient time for CIGNA to provide them to CMS at the times set forth in Section VIII thereof. It is currently anticipated that NationsHealth will use an outside vendor to monitor and provide this information on Aegis’s behalf. 
 (6) Aegis will maintain records and provide support for any CMS or HHS OIG audits of marketing and call center operations. 
 (7) If Aegis and NationsHealth agree that Aegis will respond to questions by Customers or their representatives about premium billing and collection,
Aegis will respond to such questions in accordance with protocols, policies and procedures agreed upon by CIGNA and NationsHealth pursuant to the Strategic Agreement. 
  

	 	(d)	Enrollment Communications 

 (1) Aegis will administer the enrollment process agreed upon by CIGNA and NationsHealth pursuant to the
Strategic Agreement that satisfies CMS guidelines and that includes: 
  

	 	•	 	communicating with beneficiaries who are applying for enrollment in the CIGNA Medicare Part D Prescription Drug Plan within timeframes specified by CMS or otherwise agreed upon by
NationsHealth and Aegis; 

  

	 	•	 	initiating appropriate follow up with beneficiaries who have incomplete enrollment applications within 7 calendar days of receipt of such applications or such period specified in
the SLA; and 

  

	 	•	 	making enrollments effective according to the effective date policy associated with the enrollment period in which the enrollment is received. 

 (2) Aegis will notify each Customer prior to or at the time of enrollment, of expected uses and disclosures of the Customer’s protected health
information, and the Customer’s rights and CIGNA’s duties with respect to such information. 
 (3) If the Aegis and NationsHealth
agree that Aegis will make “welcome calls,” Aegis will make a “welcome” call within such time and using such script as agreed upon by CIGNA and NationsHealth pursuant to the Strategic Agreement. 
 (4) Aegis will perform the foregoing functions in accordance with the timeliness and accuracy standards set forth in the SLA. 
 (e) Inquiry and Grievance Communications. Aegis will be responsible for communications from Customers as set forth in this Section II(e) of Exhibit A.
Aegis will administer the CIGNA Medicare Part D Prescription Drug Plan Customer inquiries and grievance procedures in accordance with CMS requirements set forth at 42 C.F.R. § 423.564 and any other guidelines established by CMS. For purposes of
this Section II(e) of Exhibit A, a “grievance” is any complaint or dispute, other than one that involves a coverage determination, expressing dissatisfaction with any aspect of CIGNA’s or any of its subcontractors’ and
providers’ operations, activities, or behavior, regardless of whether remedial action is requested. The grievance procedure is separate and distinct from the appeal procedure. The appeal procedure will be the sole responsibility of CIGNA. An
“inquiry” is any communication from a Customer that is not a grievance or an appeal. A “Customer” includes a Customer’s representative. All communications from providers will be directed to CIGNA. Aegis will be responsible
for communications from Customers as follows: 
  

	 	(1)	General Requirements 

  

	 	•	 	Aegis will enable its CSRs to accurately distinguish and classify Customer inquiries, grievances (including types of grievances), and appeals in accordance with the protocols and
definitions established or to be established by CIGNA and NationsHealth pursuant to the Strategic Agreement. 

	 	•	 	Aegis will maintain an accuracy rate as determined in the SLA in its identification and classification of inquiries, grievances, and appeals. 

  

	 	•	 	Aegis will refer all communications from providers to CIGNA and all Customer communications about mail order prescriptions covered under Part D to CIGNA. 

 

	 	(2)	Customer Telephonic Inquiries 

  

	 	•	 	Aegis will handle all telephonic inquiries by Customers or Customer representatives in a timely, courteous, professional, and culturally competent manner. 

 

	 	•	 	The service levels for timeliness and accuracy in responding to such inquiries will be the same as set forth in Section I (d)(1) of this Exhibit A. 

 

	 	•	 	Aegis will maintain and report data on telephonic inquiries in the formats and at the times set forth in Section VIII of CMS’s Final Medicare Part D Reporting Requirements.
Aegis will maintain sufficient records to support the accuracy of such reported data in the event of an audit by CMS or the HHS OIG. 

  

	 	(3)	Grievances 

  

	 	•	 	Aegis will track and address Customers’ grievances in accordance with the process agreed upon or to be agreed upon by CIGNA and NationsHealth pursuant to the Strategic
Agreement, which, in turn, will be consistent with the timelines, policies and procedures as well as definitions and protocols for identifying the different types of grievances identified in 42 CFR § 423.564 and Section V of the Final
Medicare Part D Reporting Requirements. 

  

	 	•	 	Aegis will train its staff and any permitted subcontractors involved in the grievance procedure on such policies and procedures in accordance with 42 C.F.R. § 423.564.

  

	 	•	 	Aegis will accept grievances from Customers by telephone and in writing (including facsimile and in whatever other form CMS requires CIGNA to accept grievances), and reject any that
are untimely under 42 CFR § 423.524(d)(2). 

  

	 	•	 	Fraud and Abuse grievances, as defined in Section V of the Final Medicare Part D Reporting Requirements, will be referred to CIGNA for disposition. 

	 	•	 	Aegis will notify the Customer of the grievance decision as expeditiously as the case requires, based on the Customer’s health status, but no later than 30 days after the date
Aegis receives the oral grievance; provided, that Aegis may extend the 30-day timeframe by up to 14 days if the Customer requests the extension or if Aegis justifies a need for additional information and documents how the delay is in the
interest of the Customer. When Aegis extends the deadline, it will immediately notify the Customer in writing of the reason(s) for the delay. 

  

	 	•	 	Aegis will inform the Customer of the disposition of the grievance in accordance with the following procedure: Grievances submitted orally may be responded to either orally or in
writing, unless the Customer requests a written response. 

  

	 	•	 	Aegis will respond to a Customer’s grievance within 24 hours if the complaint involves a refusal by CIGNA to grant a Customer’s request for an expedited coverage
determination under 42 C.F.R. § 423.570 or an expedited redetermination under 42 C.F.R. § 423.584, and the Customer has not yet purchased or received the drug that is in dispute. 

  

	 	•	 	Aegis will maintain, and provide upon request by CIGNA or CMS, access to records on all grievances received both orally and in writing, that includes: 

  

	 	•	 	Date of receipt of the grievance; 

  

	 	•	 	Mode of receipt of grievance (i.e. fax, telephone, letter, etc.); 

  

	 	•	 	Person or entity that filed the grievance; 

  

	 	•	 	Subject of the grievance; 

  

	 	•	 	Final disposition of the grievance; 

  

	 	•	 	Date the Customer was notified of the disposition. 

  

	 	•	 	Aegis will maintain and report data or grievances required in Section V of the Final Medicare Part D Reporting Requirements in the formats and at the times specified therein. Aegis
will maintain sufficient records to support the accuracy of such data in the event of an audit by CMS or the HHS Office of Inspector General. 

  

	 	(4)	Appeals 

  

	 	•	 	Aegis will transmit to CIGNA, as expeditiously as possible, any appeals received by Aegis. 

 EXHIBIT B 
 DATA 
 (1) Ownership of CIGNA Data. All CIGNA Data is, or will be, and will remain the
property of CIGNA and will be deemed CIGNA Confidential Information. Other than as necessary for Aegis’s performance under this Agreement, without CIGNA’s approval (in its sole discretion), the CIGNA Data will not be (a) used by
Aegis, (b) disclosed, sold, assigned, leased or otherwise provided to third parties by Aegis or to other third parties or (c) commercially exploited by or on behalf of Aegis. Aegis will not possess or assert liens or other rights in or to
CIGNA Data. To the extent applicable, Aegis hereby irrevocably and perpetually assigns, transfers and conveys to CIGNA without further consideration all of its right, title and interest in and to the CIGNA Data. Upon request by CIGNA, and at
CIGNA’s expense, Aegis will execute and deliver any financing statements or other documents that may be necessary or desirable under any Law to preserve, or enable CIGNA to enforce, its rights hereunder with respect to the CIGNA Data.

  

	 	(a)	Return of Data. Upon request by CIGNA (or by NationsHealth acting on behalf and at the direction of CIGNA) at any time during the term of this Agreement and upon expiration
or termination of this Agreement, Aegis will (a) promptly return to CIGNA, in the format and on the media requested by CIGNA, all or any part of the CIGNA Data and (b) erase or destroy all or any part of the CIGNA Data in Aegis’s
possession, in each case to the extent so requested by CIGNA. Any archival tapes containing CIGNA Data will be used by Aegis solely for back-up purposes. 

  

	 	(b)	Data Safeguards. Aegis will establish and maintain safeguards against the destruction, loss, or alteration of CIGNA Data in the possession of Aegis. 

(2) Intellectual Property. During the term of this Agreement, Aegis will assist CIGNA or its designee, at CIGNA’s expense, in every
reasonable way to secure all of CIGNA’s worldwide rights, title and interest in CIGNA Intellectual Property in any and all countries, including the disclosure to CIGNA of all pertinent information and data with respect thereto, the execution of
all applications, registrations, filings, specifications, oaths, assignments, confirmation of assignments and all other instruments which CIGNA may deem reasonably necessary or appropriate in order to apply for and obtain such rights, title and
interest and in order to assign and convey to CIGNA, its successors, assigns and nominees the sole and exclusive rights, title and interests in and to CIGNA Intellectual Property. Aegis further agrees that its obligation to execute or cause to be
executed any such instrument or papers will continue after the expiration or termination of this Agreement. If testimony or information relative to any of said matters or related to any interference or litigation is requested by CIGNA (or by
NationsHealth acting on behalf and at the direction of CIGNA) either during the term of this Agreement or following its expiration or termination, Aegis agrees to give all information and testimony and do all things reasonably requested by CIGNA (or
by NationsHealth acting on behalf and at the direction of CIGNA) and at CIGNA’s expense. If CIGNA is unable because of Aegis’s refusal or dissolution to secure a signature by or on behalf of Aegis to apply for or to pursue any application,
registration, filing or other instrument for any United States or foreign intellectual 

 
property rights covering the CIGNA Intellectual Property, then Aegis hereby irrevocably designates and appoints CIGNA and its duly authorized officers and
agents as Aegis’s agent and attorney in fact, to act for and on Aegis’s behalf and stead to execute and file any such application, registration, filing or other instrument, and to do all other lawfully permitted acts to further the
prosecution and issuance of such intellectual property rights, with the same legal force and effect as if executed by Aegis. 

 EXHIBIT C 
 DISASTER RECOVERY 
 (1) Continued Provision of Services. 

(a) Business Continuation. Aegis and NationsHealth will (i) within 30 days after the Effective Date, develop a detailed disaster
recovery and business continuation plan, including resource and infrastructure requirements that will enable Aegis to provide the Services in accordance with this Agreement, (ii) during the term of this Agreement, implement and comply with the
disaster recovery and business continuation services described in this Exhibit C and the plans developed pursuant to sub-section (a)(i) above, and (iii) test and successfully verify to NationsHealth that the disaster recovery and
business continuation plan is fully operational and capable of restoring operations so that Aegis is providing the Services as contemplated in this Agreement. Upon the discovery by Aegis of a disaster or business interruption, Aegis will promptly
provide NationsHealth with a notice of a disaster or business interruption or otherwise affecting the provision or receipt of the Services. 
 (b) Implementation of Plan and Restoration of Services. In the event of a disaster or business interruption (including a Force Majeure event, as defined in this Agreement), Aegis will implement or cause to be implemented the disaster
recovery and business continuation plan. In the event Aegis does not implement, or cause to be implemented, the disaster recovery and business continuation plan and restore the Services in accordance with such plan as set forth in this Exhibit,
NationsHealth may terminate this Agreement in whole or in part, for cause upon notice to Aegis without regard to any cure period and may pursue any and all available rights and remedies. In the event of a disaster, Aegis will not increase its
charges under this Agreement or charge NationsHealth usage fees in addition to the fees to be paid under this Agreement. The occurrence of a Force Majeure event does not excuse, limit or otherwise affect Aegis’s obligation to provide either
normal recovery procedures or any other disaster recovery services, except to the extent that such procedures or services are directly affected by such Force Majeure event. 
 (c) Alternate Source. If and for so long as any Force Majeure event prevents, or substantially hinders or delays, the performance of any
critical Service for longer than the recovery period specified in the applicable disaster recovery and business continuation plan, NationsHealth may procure part or all of the Services from an alternate source (after consultation with Aegis) in
which case NationsHealth will have no obligation to compensate Aegis for the Services for time period that the Services, or part of them, are procured from an alternate source. 

 EXHIBIT D 
 BILL OF SALE 
 THIS BILL OF SALE, dated as of
                     (the “Effective Date”), is being executed and delivered by Aegis Communications Group, Inc, having its
principal place of business at 8001 Bent Branch Drive, Irving, Texas 75063 (“Seller”), to NationsHealth, Inc., having its principal place of business at 13650 N.W. 8th Street, Sunrise, Florida 33325 (“Purchaser”). 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Seller hereby agrees as follows: 
  

	1.	Seller hereby transfers, conveys, assigns and delivers to Purchaser, all of its right, title and interest in and to all of the assets set forth on the attached Schedules (the
“Assets”). 

  

	2.	Seller, for itself and its successors and assigns, hereby covenants with Purchaser, its successors and assigns, that Seller has good right and lawful authority to sell and transfer
the Assets to Purchaser. 

  

	3.	The Assets are being transferred to Purchaser without reservation, qualification, limitation or encumbrance, and Seller agrees to defend the sale of the Assets made hereby to
Purchaser against all persons lawfully claiming the whole or part thereof. 

  

	4.	Seller hereby covenants and agrees to execute and deliver to Purchaser such instruments of sale, transfer, conveyance, assignment and delivery, and such consents, assurances, and
other instruments as may be requested by Purchaser or its counsel in order to vest in Purchaser all right, title and interest of Seller in and to the Assets and otherwise in order to carry out the purpose and intent of this Bill of Sale.

 IN WITNESS WHEREOF, Seller has caused this Bill of Sale to be executed and delivered as of this
     day of                     . 
  

							
	SELLER:	 	PURCHASER:
		
	AEGIS COMMUNICATIONS GROUP, INC.	 	NATIONSHEALTH, INC.
				
	By:	 	  
	 	By:	 	  

				
	Name:	 	  
	 	Name:	 	  

				
	Title:	 	  
	 	Title:	 	  

 EXHIBIT E 
 ASSIGNMENT AND ASSUMPTION AGREEMENT 
 THIS ASSIGNMENT AND ASSUMPTION AGREEMENT
(“Assignment”), is made as of the      day of September, 2005 by and among Aegis Communications Group, Inc, having its principal place of business at 8001 Bent Branch Drive, Irving, Texas 75063
(“Assignor”), and NationsHealth, Inc., having its principal place of business at 13650 N.W. 8th
Street, Sunrise, Florida 33325 (“Assignee”). 
 NOW THEREFORE, for good and valuable in consideration of the receipt
and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: 
  

	1.	Assignment of Agreements. Assignor hereby assigns and transfers to Assignee all of Assignor’s right, title and interest in and to the agreements set forth on the
Schedule attached hereto (the “Agreements”). 

  

	2.	Representations and Warranties of Assignors. Assignor represents and warrants that as of the date hereof: (i) the Agreements are in full force and effect;
(ii) all amounts required to be paid as of the date hereof under the Agreements have been paid; and (iii) Assignor is not in default under the Agreements. 

  

	3.	Assumption of Agreements. Assignee hereby assumes all duties, obligations, and responsibilities of the Assignor under the Agreements which accrue commencing as of the
date hereof; provided, however, Assignee expressly does not assume any duties, obligations and/or responsibilities of the Assignor under the Agreements which accrued prior to the date hereof. Furthermore, Assignee agrees to perform, observe, and
discharge all of the Assignor’s covenants and conditions under the Agreements which accrue commencing as of the date hereof. 

  

	4.	Miscellaneous. Except as modified by this Assignment, the terms, covenants, conditions and provisions of the Agreements will remain unmodified and in full force and
effect. Captions and paragraph headings contained in this Assignment are for convenience and reference only and in no way define, describe, extend or limit the scope or intent of this Assignment or any provision hereof. This Assignment and all
transactions contemplated by this Assignment will be governed by and construed and enforced in accordance with the laws of the State of Florida. This Assignment may be executed in any number of counterparts, any one and all of which will constitute
the contract of the parties and each of which will be deemed an original. 

 [SIGNATURES APPEAR ON NEXT PAGE] 

 

 C-1 

 IN WITNESS WHEREOF, the undersigned parties have executed this Assignment as of the day and year
first above written. 
  

									
	ASSIGNOR:	 		 	ASSIGNEE:
			
	AEGIS COMMUNICATIONS GROUP, INC.	 		 	NATIONSHEALTH, INC.
					
	By:	 	  
	 		 	By:	 	  

					
	Name:	 	  
	 		 	Name:	 	  

					
	Title:	 	  
	 		 	Title:	 	  

  

 C-2 

 EXHIBIT F 
 CONSENT TO ASSIGNMENT OF LEASE AGREEMENT (OR OTHER AGREEMENT) 
 The undersigned, as Licensor
(or Lessor), does hereby consent to the Assignment of the agreement attached hereto as Exhibit “A” (the “Agreement”). The aforesaid Agreement is in full force and effect. All amounts required to be paid under said
Agreement have been duly and timely paid as of the date hereof. In consideration of the assumption by Assignee of the covenants, agreements and obligations by the “licensee/lessee” to be paid, performed and kept under the Agreement,
Licensor hereby releases and discharge Assignor from any and all obligation and liability under the Agreement, and agrees to look solely to Assignee for the payment of the rentals and other sums, and for the performance and keeping of all the
covenants, agreements and conditions, to be paid, performed or kept by the “licensor/lessee” under the Agreement, but only from and after the date hereof. 
 IN WITNESS WHEREOF, Licensor has caused this Consent to be executed as of             . 
  

							
		 		 	LICENSOR:
			
		 		 	                                       
      , a
                                       
 

	 Witnesses:
	 		 		 	
	  
	 		 	
				
	 Print Name:
	 	  
	 	 By:
	 	  

				
		 		 	 Print Name:
	 	  

				
		 		 	 Title:
	 	  

	  
	 		 	
				
	 Print Name:
	 	  
	 		 	

 EXHIBIT G 
 Pursuant to Section 11 of this Agreement, this Exhibit G sets forth Section 6.07(c) of the Strategic Agreement and subsections (a), (d), (e), (f) and (g) of Section 6.05 to which 6.07(c) of
the Strategic Agreement refers: 
 “SECTION 6.07(c): 
 Option to Acquire Servicing Assets. In the event of a termination of this Agreement by CIGNA For Cause pursuant to subsections (a), (d), (e), (f) and (g) of Section 6.05, above, or in the event that
USPG and NationsHealth change their business operations such that they no longer offer the Services, then CIGNA shall have the option to acquire, which option must be exercised within thirty (30) days of the final date on which USPG renders
Services pursuant to this Agreement, the assets required to deliver all or part of the Services described in Exhibits 1.02, 1.03, 1.04, 1.05, and 1.06 . CIGNA shall have the option to acquire such physical assets from USPG and/or NationsHealth at
their fair market value. NationsHealth may decline to sell such physical assets to CIGNA, in which instance CIGNA may acquire similar assets from third party vendors. NationsHealth and/or USPG will provide know how, expertise, and personnel
resources to assist CIGNA, without cost to CIGNA, in replicating the functionality of such assets. Prior to the effective date of such termination, CIGNA may notify USPG or NationsHealth of CIGNA’s intent to exercise such option so that the
transfer of such assets will occur simultaneously with the termination. Further, in the event of such termination, CIGNA shall have the option to acquire from USPG and/or NationsHealth, without cost to CIGNA, the intangible assets required to
deliver all or part of the Services, including system specifications and configurations, software code, training and policy manuals, marketing plans and other information used by USPG or NationsHealth in the performance of the Services described in
the foregoing exhibits through a grant by USPG and/or NationsHealth to CIGNA of a royalty-free perpetual license for such intangible assets to the extent of the authority of USPG and/or NationsHealth to grant such a license.” 
 “SECTION 6.05 For Cause. “For Cause” termination shall mean the following: 
 (a) As to a nonbreaching Party, the other Party’s breach of any of the terms and conditions of this Agreement that causes a Material Adverse Effect on the
non-breaching Party, and remains uncured following written notice and a reasonable opportunity to cure, which shall not be less than ninety (90) days from the date of written notice of such breach. 
 (d) As to a nonbreaching Party, if a default occurs on a payment required to be made by the breaching Party relating to the PDP. 
 (e) As to a nonbreaching Party, if a Party is adjudicated to have committed fraud in a civil proceeding or otherwise settles a civil fraud action involving the United
States for a material amount, or a criminal action is filed by a governmental agency against a Party arising out of, or relating to, the PDP, or a Party is excluded or debarred from participation in any federal or state health care program pursuant
to 42 U.S.C. § 1320a-7. 
  

 4 

 (f) As to a nonbreaching Party, if a Party: (i) is unable to pay its debts generally as they become due;
(ii) makes a voluntary assignment for the benefit of creditors; (iii) is declared insolvent in any proceeding; (iv) commences a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to
itself, any of its property, assets or debts under any bankruptcy, insolvency or other similar laws now or hereafter in effect or petitions or applies to any tribunal for the appointment of a receiver, liquidator, custodian or trustee for such Party
under any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt, liquidation, or dissolution law of any jurisdiction now or hereafter in effect; or (v) is named as a debtor party in such petition, application, case or
proceeding and it indicates its approval thereof, consents thereto, acquiesces therein or acts in furtherance thereof, or if such petition, application, case or proceeding is not dismissed or stayed for a period of sixty (60) days after it is
commenced, or is the subject of any order appointing any such receiver, liquidator, custodian or trustee or approving the petition in any such case or proceeding. 
 (g) If a Party undergoes a change in control which shall be defined as a transfer of all, or substantially all, of the Party’s assets, or a transfer of more than (i) fifty percent (50%) as to CIGNA, or (ii) twenty-five
(25%) as to NationsHealth or USPG, of the voting control of their respective securities, in a single transaction or a series of transactions intended to effect a change in control of such Party then the Party not undergoing such change in
control may deem a For Cause termination to have occurred, provided, however that a reorganization by a Party and one or more of its Affiliates for administrative or similar purposes shall not be deemed a change in control and provided further that
as to USPG and/or NationsHealth this provision shall be limited to a change in control such that USPG and/or NationsHealth would be substantially controlled by a health plan or pharmacy benefit provider or another entity that substantially competes
with, or operates a business that substantially conflicts with, CIGNA.” 
  

 5Debt Conversion Agreement, dated November 30, 2005

 Exhibit 10.28 
  

 DEBT CONVERSION AGREEMENT 
 BY AND BETWEEN 
 AEGIS COMMUNICATIONS GROUP, INC. 
 AND 
 WORLD FOCUS INCORPORATED

 Dated as of November 30, 2005 
  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	 ARTICLE 1 TERMS OF DEBT CONVERSION
	  	2
			
	         1.1
	  	 Conversion and Release.
	  	2
			
	         1.2
	  	 Time and Place of Closing.
	  	2
		
	 ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF COMPANY
	  	2
			
	         2.1
	  	 Organization, Standing, and Power.
	  	2
			
	         2.2
	  	 Authority of the Company; No Breach By Agreement.
	  	3
			
	         2.3
	  	 Capital Stock and Conversion Shares
	  	3
			
	         2.4
	  	 Litigation.
	  	3
			
	         2.5
	  	 Brokers and Finders.
	  	4
		
	 ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF WORLD FOCUS
	  	4
			
	         3.1
	  	 Organization, Standing, and Power.
	  	4
			
	         3.2
	  	 Title to Promissory Notes.
	  	4
			
	         3.3
	  	 Authority; No Breach By Agreement.
	  	4
			
	         3.4
	  	 Litigation.
	  	5
			
	         3.5
	  	 Brokers’ Fees.
	  	5
			
	         3.6
	  	 Investment Representations.
	  	5
		
	 ARTICLE 4 CONDUCT OF BUSINESS PENDING CONSUMMATION
	  	6
			
	         4.1
	  	 Affirmative Covenants of the Company.
	  	6
			
	         4.2
	  	 Material Developments.
	  	6
		
	 ARTICLE 5 ADDITIONAL AGREEMENTS
	  	7
			
	         5.1
	  	 Agreement as to Efforts to Consummate.
	  	7
			
	         5.2
	  	 Filings with State Office.
	  	7
			
	         5.3
	  	 Confidentiality.
	  	7
			
	         5.4
	  	 Press Releases; Disclosure.
	  	7
			
	         5.5
	  	 Meeting of Stockholders.
	  	8
			
	         5.6
	  	 Preparation of Proxy Statement.
	  	8
		
	 ARTICLE 6 CONDITIONS PRECEDENT TO OBLIGATIONS TO CONSUMMATE
	  	9
			
	         6.1
	  	 Conditions to Obligations of Each Party.
	  	9
			
	         6.2
	  	 Conditions to Obligations of World Focus.
	  	9
			
	         6.3
	  	 Conditions to Obligations of the Company.
	  	10
		
	 ARTICLE 7 TERMINATION
	  	10
			
	         7.1
	  	 Termination.
	  	10
			
	         7.2
	  	 Effect of Termination.
	  	11

					
	 ARTICLE 8 MISCELLANEOUS
	  	11
			
	         8.1
	  	Survival of Representations.	  	11
			
	         8.2
	  	Definitions.	  	11
			
	         8.3
	  	Expenses.	  	14
			
	         8.4
	  	Entire Agreement.	  	14
			
	         8.5
	  	Amendments.	  	14
			
	         8.6
	  	Waivers.	  	14
			
	         8.7
	  	Assignment.	  	15
			
	         8.8
	  	Notices.	  	15
			
	         8.9
	  	Governing Law; Jurisdiction and Venue; WAIVER OF TRIAL BY JURY.	  	16
			
	         8.10
	  	Counterparts.	  	16
			
	         8.11
	  	Interpretations.	  	16
			
	         8.12
	  	Severability.	  	16

 DEBT CONVERSION AGREEMENT 
 THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of November 30, 2005, by and between Aegis
Communications Group, Inc. (“Company”), a Delaware corporation, and World Focus, an affiliate of Essar Global Limited (“World Focus”). Certain capitalized terms used in this Agreement are defined in Section 8.1
of this Agreement. 
 Preamble 
 WHEREAS, World Focus is the holder of a series of promissory notes issued by the Company, copies of which are attached hereto (the “Promissory Notes”); 
 WHEREAS, the outstanding principal and interest due and payable under the Promissory Notes as of November 14, 2005 is $18,283,690, and such
Promissory Notes will continue to accrue interest until the closing of the Debt Conversion (as defined below); 
 WHEREAS,
World Focus, and its affiliates, own a majority of the issued and outstanding Common Stock of the Company, par value $.01 per share (the “Common Stock”), which is the only outstanding class of capital stock of the Company;

 WHEREAS, World Focus and its affiliates have proposed that World Focus acquire shares of Common Stock in exchange for cancellation
of all outstanding principal and accrued interest amounts due or which may become due under the Promissory Notes (the “Debt Conversion”); 
 WHEREAS, the Board of Directors of the Company (the “Board”) has determined it to be in the best interests of the Company to consummate the Debt Conversion on fair and reasonable terms and has
appointed a special committee of independent and disinterested directors to undertake consideration of the Debt Conversion (the “Special Committee”); 
 WHEREAS, the Board has delegated to the Special Committee full and complete authority to negotiate and determine whether to approve the terms of the Debt Conversion, with full power and authority to retain such
independent legal counsel and financial advisors as the Special Committee may, in its sole discretion, deem appropriate and necessary to discharge the duties delegated to it by the Board; 
 WHEREAS, in connection with its consideration of the Debt Conversion, the Special Committee retained Legg Mason Wood Walker, Incorporated
(“Legg Mason”) to provide the Special Committee with assistance in evaluating the terms of the Debt Conversion and, to the extent appropriate, provide it with an opinion as to the fairness, from a financial point of view, of the
Conversion Price to the Company; 
 WHEREAS, the Special Committee has received the opinion of Legg Mason to the effect that, as of
November 22, 2005, the Conversion Price is fair, from a financial point of view, to the Company (the “Fairness Opinion”); 
 WHEREAS, the Special Committee has reviewed the Fairness Opinion; 
 WHEREAS, the Special Committee, based on, among
other things, its review of the Fairness Opinion and of the other terms and conditions of the Debt Conversion, has determined that it would be in the best interests of the stockholders of the Company to convert the outstanding principal amount of
the Promissory Notes and all interest accrued and unpaid as of the Closing Date into shares of Common Stock at the Conversion Price. 

 NOW, THEREFORE, in consideration of the above, and the mutual warranties, representations,
covenants, and agreements set forth herein, the Parties agree as follows: 
 ARTICLE 1 
 TERMS OF DEBT CONVERSION 
 1.1 Conversion and
Release. 
 (a) Subject to the terms and conditions of this Agreement, at the Closing, World Focus shall deliver the Promissory Notes free
and clear of all Liens, other than those transfer restrictions imposed by applicable securities Laws, in exchange for such number of shares of the Common Stock determined as set forth in the next succeeding sentence. On the Closing Date, the
Promissory Notes shall be converted into that number of shares of Common Stock (the “Conversion Shares”) determined by dividing (x) the sum of the outstanding principal amount of the Promissory Notes plus all interest
accrued and unpaid as of the Closing Date by (y) the Conversion Price. No fractional Conversion Shares shall be issued in connection with the Debt Conversion, but in lieu of such fractional shares the Company shall make a cash payment
therefor rounded up to the next one cent. 
 (b) At Closing, the Company shall deliver to World Focus, against receipt of the Promissory
Notes free and clear of all Liens, other than those transfer restrictions imposed by applicable securities Laws, a stock certificate representing the Conversion Shares. Upon receipt by World Focus of a stock certificate representing the Conversion
Shares in accordance with Section 1.1(a), World Focus hereby (i) agrees that such stock certificates shall constitute full and final satisfaction of the amounts outstanding under the Promissory Notes and (b) irrevocably releases and
discharges the Company and its Subsidiaries from any and all claims and demands it may have against the Company and its Subsidiaries pursuant to the terms of the Promissory Notes or otherwise in connection with the Promissory Notes. 
 1.2 Time and Place of Closing. 
 The transactions
contemplated by this Agreement shall take place at a closing (the “Closing”) at the offices of Pepper Hamilton LLP, 3000 Two Logan Square, Eighteenth & Arch Streets, Philadelphia, PA 19103, commencing at 9:00 A.M. on the
third (3rd) Business Day following the satisfaction or waiver of the conditions set forth in Article 6 (other
than those conditions which are to be satisfied by delivery or performance at the Closing) or at such other time and place as the Company and World Focus may mutually agree (the “Closing Date”). 
 ARTICLE 2 
 REPRESENTATIONS AND
WARRANTIES OF COMPANY 
 The Company hereby represents and warrants on the date of this Agreement to World Focus as follows: 

2.1 Organization, Standing, and Power. 
 The Company
is a corporation duly organized, validly existing, and in good standing under the Laws of the State of Delaware, and has the requisite corporate power and authority to carry on its business as now conducted and to own, lease and operate its assets.
The Company is duly qualified or licensed to transact business as a foreign corporation in good standing in the States of the United States and foreign jurisdictions where the character of its assets or the nature or conduct of its business requires
it to be so qualified or licensed, except for such jurisdictions in which the failure to be so qualified or licensed is not reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 
  

 2 

 2.2 Authority of the Company; No Breach By Agreement. 
 (a) The Company has the requisite corporate power and authority necessary to execute and deliver this Agreement, to perform its obligations under this
Agreement and to consummate the transactions contemplated hereby, all in accordance with this Agreement. The execution, delivery, and performance of this Agreement and the consummation of the transactions contemplated herein have been duly and
validly authorized by all necessary corporate action in respect thereof on the part of the Company, with the exception of the approval and adoption by the Company’s stockholders of an amendment to the Certificate of Incorporation (the
“Stockholder Approval”) to increase the number of shares of Common Stock that the Company is authorized to issue thereunder from 800,000,000 to 2,000,000,000 (the “Certificate of Amendment”). 
 (b) Assuming the due authorization and execution of this Agreement by World Focus, this Agreement represents a legal, valid, and binding obligation of
the Company, enforceable against the Company in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other Laws affecting creditors’ rights generally and except
insofar as the availability of equitable remedies may be limited by applicable Law. 
 (c) Neither the execution and delivery of this
Agreement by the Company, nor the consummation by the Company of the transactions contemplated hereby, nor compliance by the Company with any of the provisions hereof, (i) conflicts with or results in a breach of any provision of the
Company’s Certificate of Incorporation or bylaws, or (ii) constitutes or results in a default under, or require any Consent pursuant to, any Law or Order applicable to the Company. 
 (d) Except for (i) the filing of the Proxy Statement with the SEC, and (ii) the filing and recordation of the Certificate of Amendment as
required by the DGCL, no notice to, filing with, or Consent of, any Regulatory Authority is necessary to be provided, made or obtained by the Company for the consummation by the Company of the transactions contemplated in this Agreement, except
where the failure to provide, make or obtain such notifications, filings or Consents is not reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 
 2.3 Capital Stock and Conversion Shares 
 (a) The capital stock of the Company consists of:
(i) 800,000,000 shares of authorized Common Stock, of which (A) 660,053.022 shares are issued and outstanding, and (B) 475,600 are issued and held in the Company’s treasury; and (ii) 2,000,000 shares of authorized preferred
stock, $0.01 par value per share, of which (A) 29,778 shares of Series B Preferred Stock are issued and outstanding, and (B) none of which are otherwise reserved for issuance upon exercise or conversion of outstanding options, warrants,
convertible securities or other rights to purchase or otherwise obtain shares of preferred stock. 
 (b) Assuming Stockholder Approval has
been obtained and the Certificate of Amendment has been filed and recorded with the Secretary of State of the State of Delaware, the Conversion Shares, when issued and delivered in accordance with the terms of this Agreement (including against
cancellation of the Promissory Notes), will be duly and validly issued and outstanding and fully paid and nonassessable under the DGCL. 
 2.4 Litigation.

 Except for the pending matter captioned as AllServe Systems, PLC, et al. v. Aegis Communications Group, Inc., case number 061-N,
filed in Delaware Chancery Court, New Castle County, Delaware, there is no litigation, arbitration or other similar proceeding pending or, to the Company’s knowledge, threatened in writing, against the Company which seeks to enjoin, restrict or
prohibit the transactions contemplated by this Agreement. 
  

 3 

 2.5 Brokers and Finders. 
 Except for Legg Mason, neither the Company nor any of its officers, directors, employees, or Affiliates has employed any broker or finder or incurred any liability for any financial advisory fees, investment
bankers’ fees, brokerage fees, commissions, or finders’ fees in connection with this Agreement or the transactions contemplated hereby. 
 ARTICLE 3 
 REPRESENTATIONS AND WARRANTIES OF WORLD FOCUS 
 World Focus hereby represents and warrants on the date of this Agreement to the Company as follows: 
 3.1 Organization, Standing, and Power. 
 World Focus is
an entity duly organized, validly existing, and in good standing under the Laws of its jurisdiction of organization. World Focus has the requisite power and authority to carry on its business as now conducted and to own, lease and operate its
assets. World Focus is duly qualified or licensed to transact business as a foreign entity in good standing in the states of the United States and foreign jurisdictions where the character of its assets or the nature or conduct of its business
requires it to be so qualified or licensed, except for such jurisdictions in which the failure to be so qualified or licensed is not reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. 
 3.2 Title to Promissory Notes. 
 World Focus owns the
Promissory Notes, free and clear of all Liens, other than those transfer restrictions imposed by applicable securities Laws. Except for this Agreement, there are no outstanding agreements, arrangements, warrants, options, puts, calls, rights,
options, subscriptions or other commitments to which World Focus is a party relating to the Promissory Notes, or the sale, issuance or voting of the Conversion Shares. Upon delivery by World Focus to the Company of the Promissory Notes, the Company
shall acquire the Promissory Notes, free and clear of all Liens, other than those transfer restrictions imposed by applicable securities Laws. 
 3.3
Authority; No Breach By Agreement. 
 (a) World Focus has the requisite power and authority necessary to execute, deliver and perform its
obligations under this Agreement and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein, have been duly and validly authorized by
all necessary action in respect thereof on the part of World Focus. 
 (b) Assuming the due authorization and execution of this Agreement by
the Company, this Agreement represents a legal, valid, and binding obligation of World Focus, enforceable against it in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other Laws affecting creditors’ rights generally and except insofar as the availability of equitable remedies may be limited by applicable Law. 
 (c) Neither the execution and delivery of this Agreement by World Focus, nor the consummation by World Focus of the transactions contemplated hereby, nor compliance by World Focus with any of the provisions hereof,
conflicts with or results in a breach of any provision of the certificate of incorporation or bylaws (or other governing documents) of World Focus. 
  

 4 

 (d) No notice to, filing with, or Consent of, any Regulatory Authority is necessary to be provided, made
or obtained by World Focus for the consummation by World Focus of the transactions contemplated in this Agreement, except where the failure to provide, make or obtain such notifications, Consents, filings is not reasonably likely to have,
individually or in the aggregate, a Material Adverse Effect. 
 3.4 Litigation. 
 There is no litigation, arbitration or other similar proceeding pending or, to World Focus’s knowledge, threatened in writing, against World Focus
which seeks to enjoin, restrict or prohibit the transactions contemplated by this Agreement. 
 3.5 Brokers’ Fees. 
 Neither World Focus nor any of its officers, directors, employees, or Affiliates has employed any broker or finder or incurred any Liability for any
financial advisory fees, investment bankers’ fees, brokerage fees, commissions, or finders’ fees in connection with this Agreement or the transactions contemplated hereby. 
 3.6 Investment Representations. 
 (a) World Focus understands and acknowledges that the Conversion
Shares it receives, are not registered under the Securities Act of 1933, as amended (the “Securities Act”) or applicable state securities Laws, nor qualified under the securities Law of any other jurisdiction, and that the
Conversion Shares are being offered and sold in reliance upon exemptions provided by the Securities Act and certain state securities Laws for transactions not involving any public offering. 
 (b) World Focus is acquiring the Conversion Shares for investment purposes only for its own account, and not on behalf of any other Person (regardless of
whether such Person is a U.S. resident) nor with a view to, or for resale in connection with any distribution thereof). 
 (c) World Focus is
able to bear the lack of liquidity inherent in holding the Conversion Shares. World Focus has been given the opportunity to ask questions of, and to receive answers from, Persons acting on behalf of the Company concerning the business, properties,
prospects and financial condition of the Company, and to obtain additional information necessary to verify the accuracy of any information furnished to World Focus or to which World Focus has had access. 
 (d) World Focus is not a “U.S. person” (as defined in Regulation S, promulgated under the Securities Act). The offer and issuance of Conversion
Shares to World Focus constitute an “Offshore Transaction” as defined in Rule 902 of the Securities Act. World Focus is an “accredited investor” as defined in Section 501(a) of the rules and regulations adopted pursuant to
the Securities Act and, accordingly, has such knowledge and experience in financial and business matters that World Focus is capable of evaluating the merits and risks of the Debt Conversion and issuance of Conversion Shares. 
 (e) World Focus hereby agrees to resell such Conversion Shares only pursuant to registration under the Securities Act, or pursuant to an available
exemption from registration, and agrees not to engage in hedging transactions with regard to such Conversion Shares unless in compliance with the Securities Act. 
  

 5 

 (f) World Focus consents to the placement of the following legend on any certificate representing the
Conversion Shares: 
 THE SALE AND ISSUANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE DISTRIBUTION
THEREOF, AND MAY NOT BE OFFERED, SOLD, PLEDGED, OR TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT UNDER THE ACT IS IN EFFECT AS TO SUCH SECURITIES AND SUCH OFFER, SALE, PLEDGE, OR TRANSFER IS IN COMPLIANCE WITH APPLICABLE SECURITIES LAWS OF
ANY STATE OR OTHER JURISDICTION, OR (2) AN OPINION OF COUNSEL (INCLUDING INTERNAL LEGAL COUNSEL) ACCEPTABLE TO THE CORPORATION THAT AN EXEMPTION FROM SUCH REGISTRATION STATEMENT IS AVAILABLE AND SUCH OFFER, SALE, PLEDGE, OR TRANSFER IS IN
COMPLIANCE WITH APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. 
 ARTICLE 4 
 CONDUCT OF BUSINESS PENDING CONSUMMATION 
 4.1
Affirmative Covenants of the Company. 
 From the date of this Agreement until the earlier of the Closing Date or the termination of this
Agreement, unless the prior written consent of World Focus shall have been obtained, which consent shall not be unreasonably withheld, delayed or conditioned, and except as otherwise provided or permitted herein, the Company shall, and shall cause
each of its Subsidiaries to, (i) operate its business only in the usual, regular and ordinary course of the business, consistent with past custom and practice of the Company, and (ii) take no action which would (A) intentionally and
adversely affect the ability of any Party to obtain any Consents required to consummate the transactions contemplated hereby, or (B) adversely affect the ability of any Party to perform its covenants and agreements under this Agreement.

 4.2 Material Developments. 
 (a) After
it obtains knowledge thereof, the Company agrees to give written notice promptly to World Focus upon: (i) the occurrence or impending occurrence of any event or circumstance relating to the Company or any of its Subsidiaries which would
constitute a material breach of any of its representations, warranties, or covenants contained herein, and to use commercially reasonable efforts to prevent or promptly to remedy the same, (ii) any notice or other communication from any Person
alleging that the Consent of such Person is or may be required in connection with the transactions contemplated by this Agreement, or (iii) any Litigation instituted or pending, or, to the Company’s knowledge, threatened against the
Company that seeks to enjoin, restrict, or prohibit the transactions contemplated by this Agreement. 
  

 6 

 (b) From the date of this Agreement until the earlier of the Closing Date or the termination of this
Agreement, the Company shall keep World Focus advised of all material developments relevant to its ability to consummate the transactions contemplated herein. 
 (c) From the date of this Agreement until the earlier of the Closing Date or the termination of this Agreement, (i) World Focus shall keep the Company advised of all material developments related to its ability
to consummate the transactions contemplated herein and (ii) except for (A) the transfer of the Promissory Notes to the Company at the Closing as contemplated by this Agreement, or (B) World Focus shall neither transfer, sell, assign,
convey or grant any interest in, nor otherwise permit any transfer, sale, assignment, conveyance or granting of an interest in, the Promissory Notes. 
 ARTICLE 5 
 ADDITIONAL AGREEMENTS 
 5.1 Agreement as to Efforts to Consummate. 
 Subject to the terms and conditions of this Agreement,
each of the Parties hereto agrees to use, and to cause its Subsidiaries to use, all commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper, or advisable under
applicable Laws to consummate and make effective, as soon as reasonably practicable after the date of this Agreement, the transactions contemplated by this Agreement, including using commercially reasonable efforts to lift or rescind any Order
adversely affecting its ability to consummate the transactions contemplated herein and to cause to be satisfied the conditions referred to in Article 6; provided, that nothing herein shall preclude either Party from exercising its rights
under this Agreement and nothing herein shall require any Party to institute Litigation in order to obtain a Consent. 
 5.2 Filings with State Office.

 Upon the terms and subject to the conditions of this Agreement, the Company shall execute and file the Certificate of Amendment with
the Secretary of State of the State of Delaware in connection with the Closing. 
 5.3 Confidentiality. 
 Except with the prior written consent of the other Party or as required by this Agreement or applicable Law or Court Order, each Party shall, and shall
cause its advisers and agents to, maintain the confidentiality of (i) the existence, nature or terms and conditions of this Agreement and the transactions contemplated by this Agreement and (ii) all confidential information furnished to it
by the other Party concerning its and its Subsidiaries’ businesses, operations, and financial positions and shall not use such information for any purpose except in furtherance of the transactions contemplated by this Agreement. If this
Agreement is terminated prior to the Closing Date, each Party shall promptly return or certify the destruction of all documents and copies thereof, and all work papers containing confidential information received from the other Party. 
 5.4 Press Releases; Disclosure. 
 No Party to this
Agreement shall make, or cause to be made, any press release or public announcement with respect to this Agreement or the transactions contemplated hereby or otherwise communicate with any news media with respect thereto without the prior written
consent of the other Party (which consent shall not be unreasonably withheld, delayed or conditioned), and the Parties shall cooperate as to the timing and contents of any such press release or public announcement; provided, however, that
such prior written consent shall not be required for releases, announcements or 
  

 7 

 communications by a particular Party to the extent obtaining such prior written consent would prevent the timely and
accurate dissemination of information which such Party deems necessary or advisable to comply with any applicable Law. 
 5.5 Meeting of Stockholders.

 Subject to compliance with their fiduciary duties under applicable Law: (a) the Company will duly take all lawful action to call,
give notice of, convene and hold a meeting of its stockholders as soon as reasonably practicable (the “Stockholders Meeting”) for the purpose of obtaining Stockholder Approval and will its use commercially reasonable efforts to
solicit the approval and adoption by the Company’s stockholders of the Certificate of Amendment; and (b) the Board will recommend approval and adoption of the Certificate of Amendment by the Company’s stockholders and will not
(i) withdraw, modify or qualify (or propose to withdraw, modify or qualify) in any manner adverse to World Focus such recommendation, or (ii) take any action or make any statement in connection with the Stockholders Meeting that is
inconsistent with such recommendation. 
 5.6 Preparation of Proxy Statement. 
 (a) Preparation. As promptly as reasonably practicable following the date hereof, the Parties will cooperate with each other in preparing, and the
Company will cause to be filed with the SEC, proxy materials that constitute the proxy statement relating to the stockholders’ consideration of the approval and adoption by the Company’s stockholders at the Stockholders Meeting of the
Certificate of Amendment (such proxy statement and any amendments or supplements thereto, the “Proxy Statement”). The Company will use commercially reasonable efforts to have the Proxy Statement cleared by the SEC. The Company will,
as promptly as practicable after receipt thereof, provide World Focus with copies of any written comments and advise World Focus of any oral comments received from the SEC with respect to the Proxy Statement. The Parties will cooperate with each
other and the Company will provide World Focus with a reasonable opportunity to review and comment on any amendment or supplement to the Proxy Statement prior to filing such with the SEC, and the Company will provide World Focus with a copy of all
such filings made with the SEC. The Company will use commercially reasonable efforts to cause the Proxy Statement to be mailed to the Company’s stockholders as promptly as practicable after the Proxy Statement is cleared by the SEC. If at any
time prior to Closing Date any information in the Proxy Statement relating to World Focus or the Company, or any of their respective Affiliates, officers or directors, should be discovered by World Focus or the Company, as applicable, to be false or
misleading in any material respect, or that any information should be set forth in an amendment or supplement to the Proxy Statement so that the Proxy Statement would not include any misstatement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party that discovers such information will promptly notify the other Party and, to the extent required by applicable Law, an
appropriate amendment or supplement describing such information will be promptly filed with the SEC and disseminated to the Company’s stockholders. 
 (b) Information Supplied. 
 (1) None of the information supplied or to be supplied by World Focus or
the Company for inclusion or incorporation by reference in the Proxy Statement will, on the date it is first mailed to the Company’s stockholders or at the time of the meeting of the Company’s stockholders, contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. With regard to the information supplied
or to be supplied by World Focus or the Company for inclusion or incorporation by reference in the Proxy Statement, such 
  

 8 

 information will comply as to form in all material respects with the requirements of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), and the rules and regulations promulgated thereunder. 
 (2) Notwithstanding the foregoing
provisions of this Section 5.6, no representation or warranty is made by either Party hereto with respect to statements made or incorporated by reference in the Proxy Statement based on information supplied by the other Party hereto for
inclusion or incorporation by reference therein. 
 ARTICLE 6 
 CONDITIONS PRECEDENT TO OBLIGATIONS TO CONSUMMATE 
 6.1 Conditions to Obligations of Each
Party. 
 The respective obligations of each Party to perform this Agreement and consummate the transactions contemplated hereby are
subject to the satisfaction of the following conditions, unless waived by both Parties pursuant to Section 8.6: 
 (a) Regulatory
Approvals. All Consents of all Regulatory Authorities required for consummation of the transactions contemplated hereby shall have been obtained or made and shall be in full force and effect and all waiting periods required by applicable Law
shall have expired. 
 (b) Regulatory Proceedings. No Regulatory Authority shall have enacted, issued, promulgated, enforced or
entered any Law or Order (whether temporary, preliminary or permanent) or taken any other action which seeks to enjoin, restrict or prohibit the consummation of the transactions contemplated by this Agreement. 
 (c) Stockholder Approval. Stockholder Approval shall have been obtained. 
 6.2 Conditions to Obligations of World Focus. 
 The obligations of World Focus to perform this
Agreement and consummate the transactions contemplated hereby are subject to the satisfaction of the following conditions, unless waived by World Focus pursuant to Section 8.6: 
 (a) Representations and Warranties. The representations and warranties made by the Company in Article 2 of this Agreement shall be true and correct
in all material respects. 
 (b) Performance of Agreements and Covenants. Each and all of the agreements and covenants of the Company
to be performed and complied with pursuant to this Agreement and the other agreements contemplated hereby prior to the Closing Date shall have been duly performed and complied with in all material respects. 
 (c) Officer Certificates. The Company shall have delivered to World Focus (i) a certificate, dated as of the Closing Date and signed on its
behalf by its chief executive officer and its chief financial officer, to the effect that the conditions set forth in Section 6.1 (as they relate to the Company) and in Sections 6.2(a) and 6.2(b) have been satisfied, (ii) certified copies
of resolutions duly adopted by the Board and Special Committee evidencing the taking of all corporate action necessary to authorize the execution, delivery and performance of this Agreement, and the consummation of the transactions contemplated
hereby, and (iii) certified copies of resolutions duly adopted by the Company’s stockholders approving the Certificate of Amendment. 
  

 9 

 (d) Certificate of Amendment. The Company shall have delivered to World Focus a copy of the
Certificate of Amendment as filed with and certified by, the Secretary of State of the State of Delaware. 
 (e) Stock Certificates.
The Company shall have delivered to World Focus a stock certificate representing the Conversion Shares registered in the name of “World Focus”. 
 6.3 Conditions to Obligations of the Company. 
 The obligations of the Company to perform this Agreement and consummate the
transactions contemplated hereby are subject to the satisfaction of the following conditions, unless waived by the Company pursuant to Section 8.6. 
 (a) Representations and Warranties. The representations and warranties made by World Focus in Article 3 of this Agreement shall be true and correct in all material respects. 
 (b) Performance of Agreements and Covenants. Each and all of the agreements and covenants of World Focus to be performed and complied with
pursuant to this Agreement and the other agreements contemplated hereby prior to the Closing Date shall have been duly performed and complied with in all material respects. 
 (c) Officer Certificates. World Focus shall have delivered to the Company (i) a certificate, dated as of the Closing Date and signed on its
behalf by its chief executive officer and its chief financial officer, to the effect that the conditions set forth in Section 6.1 (as they relate to World Focus) and in Sections 6.3(a) and 6.3(b) have been satisfied, and (ii) certified
copies of resolutions duly adopted by World Focus’s governing body evidencing the taking of all action necessary to authorize the execution, delivery and performance of this Agreement, and the consummation of the transactions contemplated
hereby. 
 (d) Promissory Notes. World Focus shall have delivered to the Company the Promissory Notes for cancellation. 
 ARTICLE 7 
 TERMINATION

 7.1 Termination. 
 Notwithstanding
any other provision of this Agreement, and notwithstanding the receipt of Stockholder Approval, this Agreement may be terminated and the transactions contemplated hereby abandoned at any time prior to the Closing Date: 
 (a) By mutual written agreement of the Company and World Focus; or 
 (b) By World Focus (provided, that World Focus is not then in material breach of any of its representations, warranties, covenants or other agreements hereunder) in the event of a breach by the Company of any
representation, warranty, covenant or agreement contained in this Agreement, which breach or inaccuracy would, individually or in the aggregate together with all such other then breaches and inaccuracies by the Company, constitute grounds for the
conditions set forth in Section 6.2(a) or 6.2(b) not to be satisfied at the Closing Date, and which breach has not been cured within thirty (30) days after the giving of written notice to the Company of such breach; 
  

 10 

 (c) By the Company (provided, that the Company is not then in material breach of any of its
representations, warranties, covenants or other agreements hereunder) in the event of a breach by World Focus of any representation, warranty, covenant or agreement contained in this Agreement, which breach or inaccuracy would, individually or in
the aggregate together with all such other then breaches and inaccuracies by World Focus, constitute grounds for the conditions set forth in Section 6.3(a) or 6.3(b) not to be satisfied at the Closing Date, and which breach has not been cured
within thirty (30) days after the giving of written notice to World Focus of such breach; 
 (d) By either World Focus or the Company in
the event (i) any Consent of any Regulatory Authority required for consummation of the transactions contemplated hereby shall have been denied by final nonappealable action of such authority or if any action taken by such authority is not
appealed within the time limit for appeal, or (ii) if there shall be any Law or Order enacted, promulgated, issued or entered following the date of this Agreement that makes consummation of the transactions contemplated hereby illegal or
otherwise prohibited; or 
 (e) By either World Focus or the Company in the event that the transactions contemplated by this Agreement shall
not have been consummated by March 31, 2006, so long as the failure to consummate the transactions contemplated by this Agreement on or before such date shall not have been principally caused by any material breach of this Agreement by the
Party providing notice of termination. 
 7.2 Effect of Termination. 
 In the event of the termination and abandonment of this Agreement pursuant to Section 7.1, this Agreement shall become void and have no effect, except that (i) the provisions of this Section 7.2,
Section 5.3, Section 5.4 and Article 8, shall survive any such termination and abandonment, and (ii) no such termination shall relieve the breaching Party from liability resulting from any willful or intentional breach by that Party
of this Agreement. 
 ARTICLE 8 
 MISCELLANEOUS 
 8.1 Survival of Representations. 
 None of the representations and warranties contained in this Agreement or in any certificate delivered pursuant to this Agreement shall survive the Closing Date. 
 8.2 Definitions. 
 (a) Except as otherwise provided
herein, the capitalized terms set forth below shall have the following meanings: 
 “Affiliate” of a Person means:
(i) any other Person directly, or indirectly through one or more intermediaries, controlling, controlled by or under common control with such Person; (ii) any officer, director, partner, employer, or direct or indirect beneficial owner of
any 10% or greater equity or voting interest of such Person; or (iii) any other Person for which a Person described in clause (ii) acts in any such capacity. 
 “Agreement” has the meaning set forth in the recitals. 
 “Board” has the
meaning set forth in the recitals. 
  

 11 

 “Business Day” shall mean any day other than (i) a Saturday or Sunday or
(ii) a day on which banks in New York, New York are required or authorized by Law, executive order or governmental decree to be closed. 
 “Certificate of Amendment” has the meaning set forth in Section 2.2(a). 
 “Certificate of
Incorporation” means the Amended and Restated Certificate of Incorporation of the Company, as amended. 
 “Closing”
has the meaning set forth in Section 1.2. 
 “Closing Date” means the date on which the Closing occurs.

 “Common Stock” has the meaning set forth in the recitals. 
 “Consent” means any consent, approval, authorization, clearance, exemption, waiver, or similar affirmation by any Person pursuant to any
agreement, Law, Order, or Permit. 
 “Conversion Price” means $0.038 per share, subject to adjustment to reflect any
dividend, subdivision, reclassification, recapitalization, split, combination or exchange of Common Stock that may occur between the date of this Agreement and the Closing Date. 
 “Conversion Shares” has the meaning set forth in Section 1.1(a). 
 “Debt Conversion” has the meaning set forth in the recitals. 
 “DGCL” means the General Corporation Law of the State of Delaware. 
 “Exchange Act” has the meaning set forth in Section 5.6(b)(1). 
 “Fairness Opinion” has the meaning set forth in the recitals. 
 “Law” means any code, law (including common law), ordinance, regulation, reporting or licensing requirement, rule, or statute applicable
to a Person or its assets, Liabilities, or business, including those promulgated, interpreted or enforced by any Regulatory Authority. 
 “Legg Mason” has the meaning set forth in the recitals. 
 “Lien” means any conditional
sale agreement, default of title, easement, encroachment, encumbrance, hypothecation, infringement, lien, mortgage, pledge, reservation, restriction, security interest, title retention or other security arrangement, or any adverse right or interest,
charge, or claim of any nature whatsoever of, on, or with respect to any asset. 
 “Material” or
“material” for purposes of this Agreement shall be determined in light of the facts and circumstances of the matter in question. 
 “Material Adverse Effect” means, with respect to a Party, an event, change or occurrence which, individually or together with any other event, change or occurrence, has or reasonably could have a material adverse impact on
the ability of a Party to perform its obligations under this Agreement or to consummate the Debt Conversion or the other transactions contemplated by this Agreement.  
  

 12 

 “Nasdaq National Market” means the National Market System of Nasdaq Stock Market, Inc.

 “Order” means any administrative decision or award, decree, injunction, judgment, order, quasi-judicial decision or
award, ruling, or writ of any federal, state, local or foreign Regulatory Authority. 
 “Party” means either the Company or
World Focus. 
 “Person” means a natural person or any legal, commercial or governmental entity, such as, but not limited
to, a corporation, general partnership, joint venture, limited partnership, limited liability company, limited liability partnership, trust, business association, group acting in concert, or any person acting in a representative capacity.

 “Promissory Notes” has the meaning set forth in the recitals. 
 “Proxy Statement” has the meaning set forth in Section 5.6(a). 
 “Regulatory Authorities” means, collectively, the SEC, the Nasdaq National Market, the Federal Trade Commission, the Department of
Justice and all other federal, state, county, local or other governmental or regulatory courts, agencies, authorities (including taxing and self-regulatory authorities), instrumentalities, commissions, boards or bodies having jurisdiction over the
Parties and their respective Subsidiaries. 
 “SEC” means the United States Securities and Exchange Commission. 

“Securities Act” has the meaning set forth in Section 3.6(a). 
 “Securities Laws” means the Securities Act, the Exchange Act, the Investment Company Act of 1940, as amended, the Investment Advisors
Act of 1940, as amended, the Trust Indenture Act of 1939, as amended, and the rules and regulations of any Regulatory Authority promulgated thereunder. 
 “Special Committee” has the meaning set forth in the recitals. 
 “Stockholder
Approval” has the meaning set forth in Section 2.2(a). 
 “Stockholder Meeting” has the meaning set
forth in Section 5.5. 
 “Subsidiaries” means all those corporations, associations, or other business entities of which
the entity in question either (i) owns or controls 50% or more of the outstanding equity securities either directly or through an unbroken chain of entities as to each of which 50% or more of the outstanding equity securities is owned directly
or indirectly by its parent (provided, there shall not be included any such entity the equity securities of which are owned or controlled in a fiduciary capacity), (ii) in the case of partnerships, serves as a general partner,
(iii) in the case of a limited liability company, serves as a managing member, or (iv) otherwise has the ability to elect a majority of the directors, trustees or managing members thereof. 
 “World Focus” has the meaning set forth in the recitals. 
  

 13 

 (b) In this Agreement, unless otherwise specified or where the context otherwise requires: 
 (1) the headings of particular provisions of this Agreement are inserted for convenience only and will not be construed as a part of this Agreement or
serve as a limitation or expansion of the scope of any term or provision of this Agreement; 
 (2) words importing the singular only shall
include the plural and vice versa; 
 (3) words importing any gender shall include other genders; 
 (4) the words “include,” “includes” or “including” shall be deemed followed by the words “without limitation;”

 (5) the words “hereof,” “herein” and “herewith” and words of similar import, shall, unless otherwise stated,
be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; 
 (6) references to
“Articles” and “Sections” shall be to Articles and Sections of this Agreement; and 
 (7) references to any Person
include the successors and permitted assigns of such Persons. 
 8.3 Expenses. 
 Each of the Parties shall bear and pay all direct costs and expenses incurred by it or on its behalf in connection with the transactions contemplated
hereunder, including filing, registration and application fees, printing fees, and fees and expenses of its own financial or other consultants, investment bankers, accountants, and counsel. 
 8.4 Entire Agreement. 
 Except as otherwise expressly
provided herein, this Agreement (including the documents and instruments referred to herein) constitutes the entire agreement between the Parties with respect to the transactions contemplated hereunder and supersedes all prior arrangements or
understandings with respect thereto, written or oral. Nothing in this Agreement expressed or implied, is intended to confer upon any Person, other than the Parties or their respective successors, any rights, remedies, obligations, or liabilities
under or by reason of this Agreement. 
 8.5 Amendments. 
 This Agreement may be amended by a subsequent writing signed by each of the Parties upon the approval of each of the Parties, whether before or after Stockholder Approval has been obtained. 
 8.6 Waivers. 
 At any time prior to the Closing Date,
any Party hereto may (a) extend the time for the performance of any of the obligations or other acts of any other party hereto, (b) waive any inaccuracies in the representations and warranties of any other party contained herein or in any
document delivered pursuant hereto and (c) waive compliance by any other party with any of the agreements or conditions contained herein. Any such extension or waiver will be valid only if set forth in an instrument in writing signed by the
Party or Parties to be bound thereby. No failure or delay on the part of any Party hereto in the exercise of any right hereunder will impair such right or be construed to be a waiver of, or acquiescence in, any breach of any representation, warranty
or agreement herein, nor will any single or partial exercise of any such right preclude other or further exercise thereof or of any other right. 
  

 14 

 8.7 Assignment. 
 Except as expressly contemplated hereby, neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any Party hereto (whether by operation of Law or otherwise) without the
prior written consent of the other Parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and assigns. 
 8.8 Notices. 
 All notices or other communications
which are required or permitted hereunder shall be in writing and sufficient if delivered by hand, by facsimile transmission, by registered or certified mail, postage pre-paid, or by courier or overnight carrier, to the Persons at the addresses set
forth below (or at such other address as may be provided hereunder), and shall be deemed to have been delivered (a) on the date of delivery if delivered personally, or by telecopy or facsimile, upon confirmation of receipt, (b) on the
first Business Day following the date of dispatch if delivered by a recognized next-day courier service, or (c) on the fifth Business Day following the date of mailing if delivered by registered or certified mail return receipt requested,
postage prepaid: 
  

					
	Company:                        	  	Aegis Communications Group, Inc.
		  	8001 Bent Branch Drive
		  	Irving, Texas 75063
		  	Facsimile Number: (972) 868-0267
		  	Attention: Chief Executive Officer
		
		  	Hughes & Luce LLP
		  	1717 Main Street
		  	Suite 2800
		  	Dallas, Texas 75201
		  	Facsimile Number: (214) 939-5849
		  	Attention: David Luther, Esq.
		
	Copies to:	  	Special Committee of Board of Directors
		  	c/o Aegis Communications Group, Inc.
		  	8001 Bent Branch Drive
		  	Irving, Texas 75063
		  	Facsimile Number: (972) 868-0267
		  	Attention:	  	Mr. John-Michael Lind and
		  		  	Mr. Rashesh Shah
		
		  	Pepper Hamilton LLP
		  	3000 Two Logan Square
		  	18th and Arch Streets
		  	Philadelphia, Pennsylvania 19103
		  	Facsimile Number: (215) 981-4750
		  	Attention:	  	Barry M. Abelson, Esq. and
		  		  	James D. Epstein, Esq.

  

 15 

			
	 World Focus:                        
	  	World Focus
		  	Essar House, 14th Floor,
		  	KK Marg, Mahalakshmi,
		  	Mumbai 400 034, India.
		  	Tel No.:     91 22 5660 1100
		  	Fax No.:     91 22 2495 4490
		  	Attention: Mr. Surendra Agarwal

 8.9 Governing Law; Jurisdiction and Venue; WAIVER OF TRIAL BY JURY. 
 (a) Governing Law; Jurisdiction and Venue. Regardless of any conflict of law or choice of law principles that might otherwise apply, the Parties
agree that this Agreement shall be governed by and construed in all respects in accordance with the Laws of the State of Delaware. The Parties all expressly agree and acknowledge that the State of Delaware has a reasonable relationship to the
Parties and/or this Agreement. As to any dispute, claim, or litigation arising out of or relating in any way to this Agreement or the transaction at issue in this Agreement, the Parties hereto hereby agree and consent to be subject to the exclusive
jurisdiction of the state and federal courts located in Delaware. Each Party hereto hereby irrevocably waives, to the fullest extent permitted by Law, (a) any objection that it may now or hereafter have to laying venue of any suit, action or
proceeding brought in such court, (b) any claim that any suit, action or proceeding brought in such court has been brought in an inconvenient forum, and (c) any defense that it may now or hereafter have based on lack of personal
jurisdiction in such forum. 
 (b) WAIVER OF TRIAL BY JURY. AFTER CONSULTATION WITH COUNSEL, EACH OF THE PARTIES HEREBY
AGREES THAT IT WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. 
 8.10 Counterparts. 
 This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all
of which together shall constitute one and the same instrument. 
 8.11 Interpretations. 
 Neither this Agreement nor any uncertainty or ambiguity herein shall be construed or resolved against any Party, whether under any rule of construction or
otherwise. No Party to this Agreement shall be considered the draftsman. The Parties acknowledge and agree that this Agreement has been reviewed, negotiated, and accepted by all Parties and their attorneys and shall be construed and interpreted
according to the ordinary meaning of the words used so as fairly to accomplish the purposes and intentions of all Parties hereto. 
 8.12 Severability.

 Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this
Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as is enforceable. 
  

 16 

 [Signature Page Follows] 

 IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed on its behalf by
its duly authorized officers as of the day and year first above written. 
  

			
	 COMPANY:

	
	 AEGIS COMMUNICATIONS GROUP, INC.

		
	 By:
	 	 /s/ Kannan Ramasamy

	 Name:
	 	 Kannan Ramasamy

	 Title:
	 	 President and CEO

	
	 WORLD FOCUS

		
	 By:
	 	 /s/ Rajiv Agarwal

	 Name:
	 	 Rajiv Agarwal

	 Title:
	 	 Authorized Signatory

 [Signature Page to Debt Conversion Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]